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We have identified a late, committed stage in the differentiation of the mast
cell progenitor just prior to granulation.

This mast cell-committed progenitor

(MCCP) differs from the more primitive bone marrow mast cell progenitor in that
it is able to proliferate and differentiate in the absence of interleukin-3 (IL-3) when
cultured on a monolayer of embryonic skin or 3T3 fibroblasts. The MCCP can be
harvested from the mesenteric lymph nodes of mice in their fourteenth day of
infection with the rodent hookworm Nippostrongylus brasiliensis and can be cloned in
a methylcellulose culture system by supplementing the cultures with fibroblast
conditioned medium from monolayers of embryonic skin or 3T3 fibroblasts. The
mesenteric lymph node was virtually uncontaminated with hematopoietic progenitors
other than the MCCP.
The MCCP acquires a mucosal mast cell phenotype when cloned in the presence
of IL-3, but begins to take on a connective tissue mast cell phenotype when cloned
in the presence of fibroblast conditioned medium. Upon fractionation by size
exclusion chromatography, fibroblast conditioned medium contained a novel protein

X

which supported proliferation of the MCCP and a separate granulation factor;
thereby, proliferation and granulation can be uncoupled in vitro.

These data

demonstrate that IL-3 independent proliferation and differentiation of the MCCP
does not require cell contact with fibroblasts. T cell-depleted cultures consistently
produced higher numbers of mast cells than did nondepleted cultures.

IL-3

production in the mesenteric lymph node peaked at day 11 and may instrumental in
the transition of the IL-3 dependent progenitor into the MCCP.
When mast cell-deficient SI/Sid or W/W mice were infected with
Nippostrongylus, SI/Sid mice, but not W/W mice, produced the MCCP.

To

determine if these mice make the fibroblast derived factors that support development
of the MCCP, monolayers were prepared from skin connective tissues of SI/Sid and
W /W mice, and MCCP from normal mice were cloned in the presence of
conditioned medium from these monolayers. Fibroblast conditioned medium from
monolayers prepared from W/W mice, but not SI/Sid mice, was able to snpport the
development of mast cell colonies from MCCP.

Introduction

The control of cellular events leading to the phenotypic changes of differentiation
remains an important question in the study of immunology and cellular biology. The
mast cell is an attractive model for studies of cellular differentiation because it
undergoes large scale phenotypic changes in morphology, staining characteristics,
density, proteoglycan content, and cell surface receptors during its progression from
progenitor cell to mature mast cell. The signals required to induce differentiation
appear to be few as compared with other cells such as B or T lymphocytes. We have
been interested in developing an in vitro differentiation system whereby any of
several mast cell features can be studied by following the response of a late-stage
nongranulated mast cell progenitor to defined factors. To accomplish this, we have
investigated the biology of mast cell differentiation to identify the possible pathways,
different levels of cellular differentiation that occur, and the factors that support
proliferation and differentiation at key stages along those pathways.
Since the pioneering work of Taliaferro and Sarles who demonstrated the
dramatic increase of mast cells in the intestinal mucosa following helminth infection
(Taliaferro and Sarles, 1939) , the intestinal nematode Nippostrongylus brasiliensis
(Nb) has been widely used to study immunological control mechanisms associated
with intestinal mastocytosis and lgE production. Using this system, we have defined
1

2
a late, committed stage in the differentiation of the mast cell progenitor just prior to
granulation which differs from the interleukin-3 (IL-3) dependent bone marrow mast
cell progenitor in that it does not require IL-3 to proliferate or complete its
differentiation into a mature mast cell. This mast cell-committed progenitor (MCCP)
is present in the population of mesenteric lymph node cells from Nb-infected mice
(Nb-MLN). The IL-3 independent development of the MCCP can be supported by
factors which are produced by a connective tissue microenvironment such as a
monolayer of embryonic skin or 3T3 fibroblasts. Alternatively, the development of
the MCCP can also be supported by culturing it in the presence of a source of IL3 such as conditioned medium from the WEHl-3 cell line or conditioned medium
from pokeweed mitogen stimulated spleen cells (PWM-CM). The type of factor used
determines the phenotype of the mast cells that are produced.
Mature mast cells display heterogeneity and can be divided into two subsets
based upon their morphology, histochemistry, physiology, and location (summarized
in Table 1). In the study of mast cell heterogeneity, researchers have had to take an
indirect approach due to problems which stem from the inability to isolate large
numbers of mucosal or connective tissue mast cells for study. For this reason,
peritoneal mast cells have been used as the best available example of connective
tissue mast cells, and cultured mast cells from IL-3 supplemented in vitro cultures
have been used as an example of the mucosa! mast cell phenotype. Although these
studies have been very helpful in broadening the understanding of mast cell
heterogeneity, direct correlations drawn between these populations of cells versus
true connective tissue or mucosal mast cells may be in error. Connective tissue mast
cells are generally packed with small, densely staining metachromatic granules that
contain the proteoglycan heparin and large amounts of the vasoactive amine
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histamine (Galli et al., 1984a).

These connective tissue mast cells are found

primarily in the connective tissue microenvironment of the skin and subcutaneous
tissues as well as in the peritoneal cavity, and they do not require T cells or T cell
factors for growth (Galli et al., 1984a). In contrast, mucosa! mast cells have granules
which are generally larger but fewer in number, contain the proteoglycan chondroitin
sulfate but little or no heparin, and have reduced amounts of histamine (Bienenstock
et al., 1983). Because of the proteoglycan differences of these mast cell subsets, they
can be distinguished with proteoglycan specific stains. Connective tissue mast cells
are safranin positive, alcian blue negative (Enerbcick, 1966a), and their granules
exhibit yellow fluorescence when stained with berberine sulfate (Enerbcick, 1974).
In contrast, mucosa} mast cells are safranin negative, alcian blue positive, and do not
stain with berberine sulfate. Mucosa! mast cells are found in association with the
mucosa! and sur>mucosal layers of the intestinal tract and are dependent on IL-3 for
growth. There are also functional differences between the two subsets of mast cells.
Although both can be activated to degranulate in an antigen specific mechanism of
cross-linking surface IgE, only the connective tissue mast cell can be activated by the
secretagogue 48/80 (Bienenstock et al., 1982).. Mast cells can be cultured from
progenitors found in the bone marrow using IL-3 as the only growth factor. Such
culture-derived mast cells display a mucosal mast cell phenotype and therefore
contain little or no heparin (Stevens, 1986b). When the MCCP is cultured in the
presence of factors which are released from a connective tissue microenvironment,
the mast cells which develop stain with berberine sulfate and begin to stain with
safranin indicating that they are taking on a connective tissue phenotype. When
cultured only in the presence of IL-3, they stain only with alcian blue indicating a
mucosa! mast cell phenotype.

4

Mast Cell Heterogeneity

Table 1. Mast Cell Heterogeneity. This table summarizes phenotypic and functional differences
between murine mucosal mast cells and connective tissue mast cells. Information was obtained from
applicable reviews (Galli et al., 1984a; Bienenstock et al., 1983; Bienenstock et al., 1982).

5
Development of in vitro systems for studying the differentiation of mast cells was
first accomplished by Ginsburg (Ginsburg, 1963; Ginsburg, 1965; Ginsburg and
Lagunoff, 1967).

In these studies, he demonstrated that cultures of mouse

thymocytes or hyperimmune lymph node cells on embryonic monolayers yielded mast
cells after several weeks of culture.

Later studies by Ishizaka and colleagues

(Ishizaka et al., 1977; Ishizaka et al., 1976b) confirmed these observations in the rat
system and demonstrated the presence of histamine and IgE receptors in mast cells
differentiated from such cultures. These and other findings prompted Burnet to
postulate that mast cells which accumulate at sites of immune response are
postmitotic T cells (Burnet, 1975). In response to this, several groups of investigators
independently showed that T cells were required not as progenitor cells but as
inducer cells because they make a mast cell growth factor (Nabel et al., 1981;
Hasthorpe, 1980; Yung et al., 1981; Tertian et al., 1981; Schrader et al., 1981a; Razin
et al., 1981; Nagao et al., 1981). The conclusion was drawn from the observations
that mast cell proliferation and differentiation occurred in cultures of lymphoid cells
(Hasthorpe, 1980; Tertian et al., 1981) or bone marrow cells (Schrader et al., 1980;
Ishizaka et al., 1976b; Nagao et al., 1981; Schrader, 1981b; Schrader et al., 1981a)
which had been cultured in the presence of conditioned medium from T cells or T
cell-like lines. The factor capable of causing this differentiation was at first called
mast cell growth factor (Ginsburg et al., 1981; Yung et al., 1981; Nagao et al., 1981;
Razin et al., 1981; Nabel et al., 1981), P cell-stimulating factor (Clark-Lewis and
Schrader, 1981; Clark-Lewis et al., 1982), or WEHI-3 growth factor (Dexter et al.,
1980; Lee et al., 1982), but was later shown to be identical with IL-3 (Ihle et al.,
1983). These studies demonstrated a requirement for the continuous presence of IL-

6
3 for in vitro mast cell proliferation and differentiation. Huff and Justus were the
first to show that there is a point of differentiation of the mast cell precursor past
which the T cell influence is no longer required (Huff and Justus, 1988) . During
these experiments, they observed that depletion of T cells from suspensions of
mesenteric lymph node cells from Nb-infected mice resulted in no loss of mast cell
growth and differentiation, provided that the cells were cultured on monolayers of
embryonic skin. Many of these cultures actually showed increases in the number of
mast cells which develop. Using the same in vitro culture system, we have identified
the MCCP as the cell which is proliferating and differentiating into mature mast cells
in these cultures.

The MCCP intercalated into these monolayers and into

monolayers of some fibroblast cell lines; however, T cells were not able to associate
with the monolayer and could be completely washed away.
Although some attempts have been made to isolate a defined progenitor from
bone marrow (Yung et al., 1983), most studies use unfractionated bone marrow to
follow mast cell differentiation from the most primitive progenitor to a phenotypically
distinct mast cell. We have identified a way to obtain a late-stage, mast cell
committed progenitor in an environment that is virtually uncontaminated with other
hematopoietic progenitors.
The importance of fibroblasts and the connective tissue microenvironment in
the development and maintenance of the mast cell phenotype has been established
in vitro (Ginsburg et al., 1982; Fujita et al., 1988; Levi-Schaffer et al., 1985;

Levi-Schaffer et al., 1987; Levi-Schaffer et al., 1986) and in vivo (Sonoda et al., 1984;
Nakano et al., 1985; Nakano et al., 1987a; Sonoda et al., 1986b; Kobayashi et al.,
1986) using mature mast cells from various sources. Earlier studies in this laboratory
(Huff and Justus, 1988) showed that in addition to phenotype change and
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differentiation, fibroblasts were also able to support the proliferation of mast cell
progenitors. The systems that use granulated mast cells as the starting cell have
demonstrated a need for contact between the mast cell and the fibroblast monolayer,
and fibroblast conditioned supernatant was unable to support the viability of the mast
cells (Levi-Schaffer et al., 1985; Fujita et al., 1988). However, we have found that
the MCCP does not require cell-cell contact with the fibroblast monolayer for its
proliferation and differentiation. Fibroblast conditioned medium (F-CM) contains
a non-IL-3 colony stimulating factor that supports proliferation of MCCP but not the
more primitive bone marrow mast cell progenitor, and F-CM also contains a factor
that influences the phenotype of the mast cell produced. We have been successful
in separating the factors present in F-CM that support proliferation and
differentiation of the MCCP; thereby, we are able to uncouple proliferation and
granulation in vitro.

Identification of the MCCP and the discovery of distinct

connective tissue factors which separately support its proliferation and differentiation
has set the stage for development of a focused in vitro differentiation system to
individually examine discrete changes that account for the mast cell phenotype. In
addition, it has provided a unique opportunity to define the defect of two strains of
mast cell-deficient mice.
Because of the double mutant alleles at the murine W or SI locus, mice of
genotype W/W or SI/Sid have numerous abnormalities including sterility, macrocytic
anemia, and lack of hair pigmentation (Russell, 1979). In addition, Kitamura and co
workers have found that Sl/Sld and W/W mice have fewer than 1 % of the number
of mast cells found in their normal ( + / +) littermates (Kitamura and Go, 1979;
Kitamura and Hatanaka, 1978). Since those findings, mast cell-deficient mice have
been widely used to study the effect that mast cell deficiency has on the expression
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of biologic responses such as the immune response to infection (Nawa et al., 1985;
Oku et al., 1984; Mekori and Galli, 1985; Galli and Hammel, 1984b; Mitchell et al.,
1983; Crowle and Reed, 1981; Uber et al., 1980; Crowle, 1983; Ha et al., 1986;
Matsuda et al., 1987; Galli et al., 1987a; Galli and Kitamura, 1987) by comparing the
response of mast cell-deficient mice to their + / + littermates. These mice have also
proven to be valuable tools in the in vivo study of mast cell biology including mast
cell function, differentiation, and heterogeneity (Sonoda et al., 1984; Nakano et al.,
1985; Nakano et al., 1987a; Nakano et al., 1986; Kitamura et al., 1979b; Hayashi et
al., 1985; Suda et al., 1985a; Sonoda et al., 1986b; Sonoda et al., 1986a; Otsu et al.,
1987; Nakano et al., 1987b; Fujita et al., 1988). However, the interpretation of
results from these studies is necessarily limited and difficult because the basis for the
mast cell deficiency in these mice is not clearly understood. Also, the numerous
other abnormalities present in these mice raise the possibility that differences in their
biologic response may not be strictly mast cell dependent. Until the cause for the
mast cell deficiency in these mice is known and the gene product of the mutant
alleles identified, the limits of interpretation prohibit the full potential of functional
studies from being realized.
Having identified the MCCP and the factor which supports its proliferation, we
investigated the possibility that the mast cell deficiency of W/W or Sl/Sld mice may
be explained by either an inability to produce the MCCP or the factor that supports
the proliferation of the MCCP. The mechanism of mast cell deficiency in W /W
mice is distinct from Sl/Sld mice (Galli and Kitamura, 1987; Kitamura et al., 1986a).
The mast cell deficiency in W/W mice is thought to be the consequence of a defect
at the level of the bone marrow, most likely an intrinsic defect in an early stem cell
(Kitamura and Hatanaka, 1978; Sonoda et al., 1984). In contrast, the Sl/Sld mouse
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is thought to have a defect in the connective tissue microenvironment which prohibits
the normal development of mast cell progenitors (Kitamura and Go, 1979; Hayashi
et al., 1985). These theories are supported by numerous observations by Kitamura
and his colleagues including the report that intravenous injection of bone marrow
cells from Sl/Sld mice cured the mast cell deficiency of W /W mice (Kitamura and
Go, 1979); however, bone marrow cells from + / + mice do not cure the mast cell
deficiency in Sl/Sld mice (Kitamura et al., 1986b).
To determine if mast cell-deficient mice could produce the MCCP, mice were
infected with Nb and their mesenteric lymph node cells (Nb-MLN) were cloned in
methylcellulose using 3T3 F-CM as the source of growth factors. In another group
of experiments to determine if mast cell-deficient mice make the appropriate factors
to support the MCCP, normal BALB/c mice were infected with Nb and their Nb
MLN were cloned in the presence of F-CM from monolayers of skin connective
tissues which were prepared from mast cell-deficient mice. We found that W/W
mice failed to make the MCCP whereas Sl/Sld mice produced a normal number of
these progenitors. However, F-CM prepared from connective tissue monolayers from
W/W mice was able to support proliferation and differentiation of normal MCCP
harvested from BALB/c mice whereas F-CM from Sl/Sld lacked this activity. These
findings may be instrumental in the future identification of the gene product of each
of these mutant alleles.

Literature Review

Mast cells differ from basophils
In 1878, Paul Ehrlich was the first to describe a cell which contained large
granules in the cytoplasm which tightly bound basic dyes (Ehrlich, 1878). This cell,
which we now call the mast cell, was found in connective tissues and in the peritoneal
cavity. The following year, Ehrlich also described the basophil, a cell with similar
features which circulated in the blood (Ehrlich, 1879).
The mast cell and basophil are similar in that both are a maJor source of
powerful chemical mediators of inflammation and other immunological events (Lewis
and Austen, 1981), and both express high affinity IgE receptors that specifically bind
the Fe portion of the IgE molecule thereby becoming sensitized (Ishizaka, 1984;
Ishizaka, 1976; Ishizaka, 1985; Ishizaka and Ishizaka, 1975). Sensitized cells undergo
degranulation when the IgE on their surface becomes crosslinked with a specific
multivalent antigen, or when molecules on the cell surface become linked by specific
antibody (Ishizaka and Ishizaka, 1978; Ishizaka and lshizaka, 1978; Ishizaka et al.,
1980). Alternatively, degranulation of basophils and mast cells may be brought about
by various non-immunological agents such as lectins, complement fragments, basic
peptides, or trauma (Galli et al., 1984a; Ishizaka et al., 1985).
Although similar, basophils and mast cells have many differing features that
distinguish them as two distinctly different cells. These features include nuclear
10
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morphology, location in vivo, mediator content, function, and response to chemical
agents (Galli et al., 1984a; Schwartz and Austen, 1984; Schwartz, 1983b). Basophils
are thought to be terminally differentiated granulocytes which complete their
differentiation in the bone marrow before being released as a mature cell to circulate
in the blood (Denburg et al., 1985). Basophils are not normally found in connective
tissue, and when they do migrate into tissues, they maintain their morphological
appearance including their multi-lobed nucleus.

In contrast, mast cells are

distributed in connective tissue throughout the body (Yong, 1981; Pearce et al., 1982;
Barrett and Metcalfe, 1987), especially beneath epithelial surfaces of the skin,
gastrointestinal tract, or respiratory tree, where they are exposed to environmental
antigens.

Mature mast cells do not circulate in the blood.

Although some

investigators continue to search for evidence that basophils give rise to mast cells
(Zucker-Franklin, 1980), the general consensus of most researchers in the field is that
the mast cell is an entirely separate lineage (Galli, 1987b). The presence of potent
immunological mediators in the mast cell granule including heparin (Katz et al.,
1986; Serafin et al., 1986; Stevens et al., 1986a; Enerback et al., 1985; Seldin et al.,
1985; Bland et al., 1982; Schwartz et al., 1982; Schwartz et al., 1981; Stevens and
Austen, 1981; Metcalfe et al., 1980; Gustafsson and Enerback, 1978), histamine
(Shore, 1971; Kida et al., 1985b; Dayton et al., 1988), proteases (Schick and Austen,
1985; DuBuske et al., 1984; Schwartz et al., 1983a; Schwartz and Austen, 1981;
Newlands et al., 1987), leukotrienes (Mencia-Huerta et al., 1983; Razin et al., 1983;
Razin et al., 1982a; Razin et al., 1984a; Lewis and Austen, 1981), prostaglandins
(Lewis et al., 1982; Lewis et al., 1981), and a variety of other potent mediators
(Schwartz, 1983b; Schwartz and Austen, 1984; Serafin et al., 1987; Everitt and
Neurath, 1980) has attracted attention to the study of mast cells and their role in
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inflammation and other immune mechanisms.
Even before a consensus had been reached concerning the basophil/mast cell
controversy, it was becoming very clear that mast cells were not a homogeneous
population. Complicating matters further was the rapidly growing evidence that
major differences exist between mast cells from different species (Kaliner, 1980;
Bienenstock et al., 1985; Bienenstock et al., 1983; Befus et al., 1985).

Mast cell heterogeneity
Ehrlich's description of the mast cell was based on the metachromatic staining
properties of its cytoplasmic granules (Ehrlich, 1878). However in 1905, Maximow
found that certain mast cells in the rat intestinal mucosa differed in staining
properties from mast cells found in the skin, and he called these mucosal mast cells
"atypical" (Maximow, 1905). All species examined thus far have these two subsets of
mast cells (Bienenstock et al., 1985; Katz et al., 1985a), and many investigators have
agreed to use the terminology of mucosal or connective tissue mast cell. Enerback
demonstrated that there were histochemical differences between connective tissue
and mucosal mast cells (Enerback, 1966a), and made the important discovery that
in contrast to connective tissue mast cells, mucosa} mast cells could not be observed
in tissue that had been fixed in formalin (Enerback, 1966b). He demonstrated that
other fixatives such as Camoy's or Mota's lead acetate made visualization of the
mucosa} mast cell possible. Many studies before his work had employed formalin as
a routine fixative.
Because of the inability to isolate large numbers of mucosal or connective tissue
mast cells for study, peritoneal mast cells have been used as the best available
example of connective tissue mast cells, and cultured mast cells from IL-3
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supplemented in vitro cultures have been used as an example of the mucosal mast
cell phenotype. Thus in the study of mast cell heterogeneity, researchers have had
to take an indirect approach, and this has had bmad negative implications on the
ability to draw meaningful conclusions from the data. Differences may exist between
the peritoneal mast cell, which is in a serosa-lined body cavity, as compared to true
connective tissue mast cells which are in tissue in direct contact with fibroblasts.
Adding to the difficulty are the reports that peritoneal cavity-derived mast cells
display heterogeneity which may reflect differing stages of maturity (Pretlow and
Cassady, 1970). Differences also exist between the true mucosal mast cell and the
cultured mast cell, which is the product of weeks of in vitro culture in the presence
of high levels of IL-3. Differences between the murine cultured mast cell and the
mucosa! mast cell have been documented in ultrastructure (Galli et al., 1982; Tertian
et al., 1981), histamine content (Galli et al., 1982; Nabel et al., 1981; Nagao et al.,
1981; Razin et al., 1981; Schrader, 1981b; Sredni et al., 1983), content of serotonin
(Weitzman et al., 1985), level of sulfated glycosaminoglycans (Razin et al., 1982b;
Sredni et al., 1983), and the number of high affinity IgE receptors (Galli et al., 1982).
Nonetheless, there are many ways in which cultured mast cells are similar to the
mucosal mast cells that proliferate during responses to intestinal parasites (Galli,
1986; Galli et al., 1982; Sredni et al., 1983), and thus cultured mast cells have been
employed for most studies of heterogeneity.
A major difference between mucosal and connective tissue mast cells is the type
of glycosaminoglycans that each produces (Stevens, 1986b; Stevens and Austen,
1981). Murine mucosal mast cells produce poorly sulfated glycosaminoglycans which
are complexed with a core protein to produce the proteoglycan chondroitin sulfate
E (Serafin et al., 1986; Stevens et al., 1985; Razin et al., 1984b; Stevens et al., 1983;
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Razin et al., 1982b). Chondroitin sulfate E can be analyzed in a number of ways
including enzymatically (Saito et al., 1968) or by high-performance liquid
chromatography (Seldin et al., 1984). Mucosal mast cells do not contain heparin
unless they are cocultured in the presence of fibroblasts (Bland et al., 1982;
Levi-Schaffer et al., 1986). In contrast, murine connective tissue type mast cells
make primarily heparin proteoglycan (Tas and Berndsen, 1977; Stevens et al., 1987;
Razin et al., 1982b). Although the glycosaminoglycans of heparin differ from those
of chondroitin sulfate, the core protein of each is identical and comes from a single
gene (Tantravahi et al., 1986; Bourdon et al., 1987).
These negatively charged proteoglycans cause mast cells to display differing
staining characteristics which have been useful to investigators.

All mast cell

granules bind the dye toluidine blue. These cells then stain metachromatically, thus
the granules display a characteristic red color (Enerback, 1966a).

This

metachromasia is still used as the standard method to distinguish mast cells from
other lineages. Enerback also found that connective tissue mast cells have a higher
affinity for some cationic dyes than do mucosal mast cells. He demonstrated that
when mast cells are stained with alcian blue and counterstained with safranin, the
granules of connective tissue mast cells stain pink whereas the granules of mucosa}
mast cells stain blue (Enerback, 1966a). The presence of heparin in connective
tissue mast cells can be detected by the use of the cationic dye berberine sulfate.
This dye binds to the sulfate-containing polyanions in heparin but not to chondroitin
sulfate (Enerback, 1974; Dimlich et al., 1980). Once bound to berberine sulfate, the
heparin-containing granules exhibit bright yellow fluorescence. All of these staining
methods to determine mast cell heterogeneity have proven to be very valuable and
are still widely used.
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Another major difference between murine mucosal mast cells and connective
tissue mast cells is their different level of biogenic amines such as histamine and
serotonin (Schwartz and Austen, 1984; Bienenstock et al., 1983; Bienenstock et al.,
1982). Connective tissue mast cells have as much as 10-fold the amount of histamine
as compared to mucosal mast cells. The latter has little or no serotonin. Although
most work has been done in the rat (Shanahan et al., 1986; Katz et al., 1986; Everitt
and Neurath, 1980; Bienenstock et al., 1982), there is some evidence for similar
indicators of heterogeneity in murine mast cells.
Mucosal mast cells appear to have fewer granules and a shorter life span (less
than forty days) as compared to connective tissue mast cells which are thought to
survive a year or more (Galli et al., 1984a). Connective tissue mast cells, but not
mucosal mast cells, degranulate in response to compound 48/80 (Galli et al., 1984a).
In the rat, proteases have been found to be the best method to differentiate between
the two mast cell subsets (Gibson et al., 1987; Mcmenamin et al., 1987; Newlands et
al., 1987; Kido et al., 1985a; Schwartz, 1983b; Schwartz and Austen, 1984).
Connective tissue mast cells show high levels of chymase (rat mast cell protease I)
whereas mucosal mast cells have a second type of chymotryptic protease called rat
mast cell protease II. These two proteases can be distinguished with monoclonal
antibodies in fixed tissue (Schwartz and Austen, 1984) with little or no cross
reactivity; however, in the mouse, antibodies have only been raised against the
chymotrypsin-like enzyme found in the mucosal mast cell (Newlands et al., 1987), and
work has not been done to determine if proteases will be an important indicator of
murine mast cell heterogeneity.
Katz et al. have described a panel of monoclonal antibodies that distinguished
the two subsets of murine mast cells (Katz et al., 1983; Katz et al., 1985a).
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Hybridoma

Bl.1 makes

an

antibody

that

binds

the

glycospbingolipid,

globopentaosylceramide, which is also known as the Forssman antigen. Of the two
mast cell subsets, only connective tissue mast cells express this antigen (Katz et al.,
1985b). Another hybridoma (B54.2) produces antibody that recognizes a glycoprotein
complex which is expressed on both mast cell subsets (Katz and Austen, 1987). A
third hybridoma (B23.1) produces antibody that recognizes an unknown antigen
which is expressed on the surface of mucosa! mast cells but not connective tissue
mast cells (Katz et al., 1983). Thus connective tissue mast cells are Bl.1 + , B23.1-· and
B54.2 + , whereas mucosa! mast cells are Bl.f· B23.1 + , and B54.2 + . The same group
bas also noted that murine cultured mast cells express the acidic glycosphingolipid,
ganglioside GM1 (Katz et al., 1987). These markers hold promise of being important
tools in distinguishing mast cell subsets in the mouse.
The most important biological distinction between mast cell subsets may be that
only mucosa! mast cells are dependent upon T cells or T cell products for
proliferation. Although mice are known to develop a mastocytosis in response to
infection with Trichinella spiralis (Oku et al., 1984; Alizadeh and Wakelin, 1982;
Parmentier et al., 1987; Ruitenberg and Elgersma, 1976), mucosa! mast cells do not
proliferate in Trichinella-infected athymic nude mice (Ruitenberg and Elgersma,
1976) or in Nb-infected T cell-depleted mice (Olson and Levy, 1976). However,
athymic mice do generate a mucosa! mast cell response if their T cell function is
restored by thymic transplantation (Ruitenberg and Elgersma, 1976). The numbers
of cutaneous or peritoneal mast cells are not reduced in athymic mice (Ruitenberg
and Elgersma, 1976). These data support the hypothesis by Ginsburg et al. that there
might be two modes of mast cell growth, one dependent on T cell factors while the
other is not (Ginsburg et al., 1982). It is now known that IL-3 can be used in vitro
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to produce cultured mast cells that resemble the mucosal mast cell phenotype;
however, no one has yet identified a mechanism for the proliferation of connective
tissue mast cells.

IL-3 as a mast cell &rowth factor
At the same time several laboratories were finding that mast cell proliferation
and differentiation could be supported in vitro with the supernatant from activated
T cells (Schrader et al., 1980; Yung et al., 1981; Tertian et al., 1981; Schrader, 1981b;
Razin et al., 1981; Dy et al., 1981; Clark-Lewis and Schrader, 1981; Yung and Moore,
1982), a group led by Ihle reported a novel lymphokine that induced the expression
of 20 o-hydroxysteroid dehydrogenase in splenic lymphocytes (Ihle et al., 1981a; Ihle
et al., 1981b). This lymphokine was designated IL-3, and was shown to regulate the
growth and differentiation of some lymphocytes (Ihle et al., 1981b; Hapel et al.,
1981; Ihle et al., 1982a; Ihle et al., 1982b; Hapel et al., 1982). It was quickly realized
that in addition to T cell regulation, IL-3 also served as a colony stimulating factor
for multiple lineages of bone marrow-derived cells (Prystowsky et al., 1984; Prestidge
et al., 1984; Watson and Prestidge, 1983; Schrader et al., 1983a; Schrader et al., 1983;
Schrader and Crapper, 1983b). In 1983, Ihle and his colleagues demonstrated that
all of these biological activities could be accounted for by homogeneous preparations
of IL-3 (Ihle et al., 1983). Later it was found that the colony stimulating activity of
IL-3 was a result of its ability to recycle the pluripotent bone marrow progenitor
(CFU-S) in vitro (Spivak et al., 1985; Suda et al., 1985b; Ihle and Keller, 1985;
Spooncer et al., 1986; Metcalf et al., 1986) and in vivo (Lord et al., 1986; Kindler et
al., 1986; Metcalf et al., 1987). IL-3 has also been shown to synergize with other
growth factors to promote their normal activity (Chen and Clark, 1986; Robinson et
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al., 1987; Koike et al., 1987). In 1986, a series of papers were published from
Ogawa's laboratory which demonstrated that the interaction of IL-3 with other colony
stimulating factors demonstrates a hierarchical pattern of the regulation of
differentiation (Koike et al., 1986a; Koike et al., 1986c; Koike et al., 1986b). The
gene for IL-3 has been cloned in the mouse (Yokota et al., 1984; Fung et al., 1984;
Rennick et al., 1985; Miyatake et al., 1985), the rat (Cohen et al., 1986), and in man
(Dorssers et al., 1987). Investigators have been successful in producing antiserum
against IL-3 (Bowlin et al., 1984) but monoclonal antibodies are not commercially
available. Synthetically produced IL-3 has been shown to express biological activity
(Clark-Lewis et al., 1986).
In studies which were completed long before the identification of IL-3, Iscove
et al. found that conditioned medium from pokeweed mitogen-stimulated spleen cells
was an ideal source of growth factors for cloning hematopoietic progenitors (Iscove
et al., 1974). This conditioned medium is now known to be a rich source of IL-3 and
other factors and is still widely used (Nakahata et al., 1982; Pharr et al., 1984).

Origin, proliferation, and differentiation of mast cells
Although mast cells had been thought to be derived from undifferentiated
mesenchymal cells, transplantation experiments showed their origin to be from the
bone marrow (Kitamura et al., 1977; Kitamura et al., 1979b). As further evidence,
it was observed that the intravenous transfer of cells from a single spleen colony
formed by injecting bone marrow cells into irradiated mice resulted in development
of mast cells in the spleen and stomach of W/W mice (Kitamura et al., 1981). After
it was known that IL-3 could be added to mast cell cultures to enhance the
proliferation of mast cells in vitro, work on the origin and differentiation of mast cells
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began to accelerate. It was found that colonies produced in vitro from mouse bone
marrow produced mast cells when injected into the skin of mast cell-deficient W/W
mice, and Nakahata et al. reported that mixed bone marrow colonies contain mast
cells (Nakahata et al., 1982). Unlike other hematopoietic progenitors, mast cell
progenitors must leave the bone marrow and complete their differentiation in a
connective tissue microenvironment (Kitamura et al., 1979a), thus many investigators
have been interested in determining the mechanism of differentiation of the bone
marrow mast cell progenitor in vivo and in the factors which influence the final
phenotype achieved.
Several theories and models have been proposed to explain stem cell renewal
and the acquisition of commitment into various cell lineages. A stochastic model
where a stem cell randomly expresses receptors for different growth factors has been
hypothesized (Korn et al., 1973). This model provides for dissimilar patterns of
differentiation of two daughter cells, and progeny could therefore differentiate down
different lineages depending on the growth factors and the concentrations of those
factors that were available at that time. This model is supported by the concept of
a hematopoietic inductive microenvironment, sometimes referred to as "HIM". HIM
is the effect of connective tissue stroma on the concentration of growth factors for
hematopoietic progenitors (Tavassoli and Friedenstein, 1983).

Splenic HIM

encourages preferential differentiation of the erythroid lineages, whereas
granulopoiesis is preferred in the bone marrow.
Another interesting model (Quesenberry, 1983) involves hierarchical down
regulation of growth factor receptors, and evidence for this type of regulation has
been accumulating (Walker et al., 1985; Nicola, 1987a; Nicola, 1987b). There are
four glycoprotein colony stimulating factors that provide for the proliferation and
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differentiation of hematopoietic progenitors. These four factors, IL-3, GM-CSF, G
CSF, and M-CSF, are separate gene products that bind to distinct, specific receptors
(Nicola, 1987a).

Ligand binding to the receptor leads to internalization and

degradation of the complex, and the degradation products are thought to be the
signal for differentiation. Walker and Burgess have shown that although these
factors do not compete directly for each other's binding sites, they are able to quickly
down-modulate receptors for other factors on bone marrow cells (Walker and
Burgess, 1985). At moderate concentrations of growth factor, IL-3 down-modulates
the expression of GM-CSF, G-CSF, and M-CSF receptors. GM-CSF down modulates
the expression of G-CSF and M-CSF receptors, but not receptors for IL-3. At
moderate concentrations, neither G-CSF nor M-CSF can down modulate the
expression of receptors for IL-3 or GM-CSF. It appears that these colony stimulating
factors may exert their differentiation-inducing activities by these receptor trans
down-modulations so that lineage-specific receptors can be activated by binding their
own specific ligand or by trans-down-modulation. In either case, the result is that
there is initiation of a series of cell divisions that lead to the production of precursors
which are committed to one of several specific lineages.
Other models including the determinative theory (Wolf and Trentin, 1970), the
lymphocyte-transitional model (Tavassoli and Friedenstein, 1983), and the effector
memory cell model (Ginsburg et al., 1986), have been proposed. Whatever the
mechanism may be, it is clear that mast cells are the progeny of the hematopoietic
stem cell in the bone marrow (Kitamura et al., 1981; Schrader, 1981b; Nakahata et
al., 1982; Schrader et al., 1981a); however, they do not complete their differentiation
in hematopoietic tissue. Although virtually no mast cells are found in peripheral
blood, when blood mononuclear cells were directed into the skin of W/W mast cell-
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deficient mice, mast cell colonies form at the injection site (Sonoda et al., 1983).
Mast cell precursors are known to leave the blood stream and enter connective tissue
or mucosa! tissues where they proliferate before differentiating into mature mast cells
(Kitamura et al., 1979b; Hatanaka et al., 1979).
In contrast to other granulocytes of bone marrow origin, mast cells appear to
be extremely long-lived and at least some maintain the potential to proliferate.
When peritoneal mast cells were individually injected into the skin of W/W mice,
mast cell colonies developed at the injection sites (Sonoda et al., 1984). However,
it is extremely rare to identify mitotic mast cells in tissue, thus it is believed that
mature mast cells which can still undergo proliferation must first dedifferentiate (i.e.
degranulate). Once dedifferentiated, the cell can then undergo proliferation and
then redifferentiate into a mature mast cell (Kitamura et al., 1986a).
The probable dedifferentiation and proliferation of mast cells has been compared
to the blastogenesis of T lymphocytes (Lee et al., 1986), and it is interesting that the
murine lymphokine IL-4 stimulates the growth of both T cells and mast cells (Lee
et al., 1986). Further studies with IL-4 have shown that although IL-4 alone is not
sufficient to stimulate the growth of mast cells, the combination of IL-4 and IL-3
increased the numbers of mast cell colonies produced in vitro from connective tissue
mast cells by one order of magnitude over IL-3 alone (Hamaguchi et al., 1987).
Others have also shown that IL-4 also potentiates the growth of mucosa! mast cells
(Smith and Rennick, 1986; Mosmann et al., 1986), as well as the growth and
differentiation of all bone marrow hematopoietic progenitors (Peschel et al., 1987).
Thus, it appears that IL-4 is an important factor for in vitro clonal proliferation of
both subsets of mast cells and a variety of other progenitors.
Another cytokine that has been implicated in development of mast cells is nerve
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growth factor (NGF). NGF is known to be produced by murine fibroblast cell lines
(Oger et al., 1974), and became of interest when it was noted that intestinal mucosa!
mast cells were in intimate contact in peptidergic nerves in normal or Nb-infected
rats (Stead et al., 1987). Also, it was found that injection of NGF into neonatal rats
induces a dose dependent increase in the numbers of both connective tissue and
mucosa! mast cells (Bienenstock et al., 1987); however, it is unknown if this is a
direct or indirect effect. Until more is known about mast cell/nerve interaction, no
firm conclusion can be made concerning NGF as a mast cell growth factor.
Galli et al. used clones of IL-3 dependent cultured murine mast cells to evaluate
whether mast cells could be induced to mature in vitro (Galli et al., 1982). Their
approach was to use sodium butyrate, because it was known to increase development
of cytoplasmic granules and storage of mediators in the granules of a murine
mastocytoma cell line. They found that sodium butyrate-treated mast cells increased
stores of histamine and chondroitin sulfate, and also had a decreased capacity to
proliferate. However, these treated mast cells did not synthesize heparin. The
interpretation of these data was that the treated mast cells had undergone a partial
maturation, but they had not begun to take on a connective tissue mast cell
phenotype.
More recent studies of mast cell differentiation have focused on the possibility
that the two subsets of mast cells are not only from the same lineage, but also have
the ability to transdifferentiate, i.e., either subset may switch its phenotype to become
the other type of mast cell. When cultured mast cells were produced in vitro by
stimulation with IL-3, their phenotype changed from mucosal mast cells to connective
tissue mast cells upon injection into the peritoneal cavity of W/W mice (Otsu et al.,
1987; Nakano et al., 1985; Nakano et al., 1987a). In another approach, mast cell
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cultures were produced from connective tissue mast cells in the peritoneal cavity, and
individual colonies were divided in half. One half of the colony was injected into the
skin of W/W mice, while the other half was injected into the stomach wall.
Connective tissue mast cells developed in the skin and muscularis propria of the
stomach, but mucosal mast cells developed in the mucosa of the stomach (Kobayashi
et al., 1986). These studies were confirmed by the observation that mucosal mast
cells develop from the injection of a single connective tissue mast cell into the
stomach mucosa of W/W mice (Sonoda et al., 1986b). Taken together, these studies
demonstrate that mast cells of either subtype can function as a bipotent mast cell
progenitor that differentiates into either a mucosal mast cell or a connective tissue
mast cell depending on the environment in which that final differentiation occurs.
From these studies it is not clear whether dedifferentiation must occur before
transdifferentiation, or if one phenotype can transdifferentiate directly to the other
phenotype without degranulation.
The demonstration by the Kitamura group that the environment in which a mast
cell differentiates in vivo determines its final phenotype is supported by in vitro
studies conducted by others (Levi-Schaffer et al., 1985). These studies showed that
rat connective tissue mast cells could be maintained for 30 days in vitro when
cocultured on a living monolayer of the murine fibroblast cell line 3T3 (Levi-Schaffer
et al., 1985). However, the mast cells could not be maintained with fibroblast
conditioned medium, dead fibroblasts, or extracellular matrix-coated culture dishes.
The cocultured connective tissue mast cells continued to synthesize heparin and could
be activated to degranulate by crosslinking IgE on their surface.

When IL-3

dependent cultured mast cells were cocultured on a fibroblast monolayer in the
presence of IL-3, they became adherent to the fibroblasts within two days. By one
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week of culture, nearly all mast cells exhibited a mixed staining in which half of the
granules in each cell were safranin positive and the other half were safranin negative
(Levi-Schaffer et al., 1986). The cocultured mast cells increased their histamine
content 15-fold and began to display globopentaosylceramide on their surface as
evidenced by their ability to bind the monoclonal antibody produced by Bl.1.
However, when these murine cultured mast cells were cocultured with 3T3 fibroblasts
in the absence of IL-3, they did not proliferate and did not increase their cellular
histamine content (Levi-Schaffer et al., 1986). Based on these data, the authors
concluded that coculture of cultured mast cells induces a phenotypic change toward
the connective tissue mast cell, whereas the presence of IL-3 stimulates proliferation
and an increase in histamine content. Katz and his colleagues have shown that when
murine cultured mast cells are cocultured with 3T3 fibroblasts, the fibroblasts were
stimulated to synthesize globopentaosylceramide, and the surface expression of this
molecule was increased on both the fibroblasts and the mast cells (Katz et al., 1988).
This suggests that mast cells may stimulate the synthesis and secretion of this neutral
glycosphingolipid and the appearance of this molecule on the surface of mast cells
is due to its adsorption to the mast cell surface. This could prove to be an important
mechanism of how the fibroblast controls the final phenotype of the mast cell which
matures in a connective tissue microenvironment.

The host response to infection with Nippostrongylus as a research model
Taliaferro and Sarles were the first to use the Nb infection as a tool to induce
mastocytosis and the associated increase in lgE production as a research model
(Taliaferro and Sarles, 1939). Since then, the Nb infection has been an important
part of many different approaches to the study of mast cell biology, IgE production,
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and the immunological mechanisms involved in the parasitic relationship between
helminths and hosts (Ogilvie and Jones, 1971; Ogilvie and Jones, 1973). These
studies have shown that Nb undergoes expulsion from the gut of experimentally
infected rodents starting approximately 10 to 14 days after primary infection (Befus
and Bienenstock, 1984; Befus and Bienenstock, 1982; Miller, 1971; Miller and Jarrett,
1971), and this expulsion is brought about by a complex interaction of cellular
immunity, humoral immunity, and innate immunity. Although not clearly understood,
it appears that production of antibody at the mucosa! surface damages the adult
worms, thus the host can be protected by passive immunization with antiserum from
infected donors. Interestingly, the protective antibody was primarily from the IgG
class, and neither IgA nor IgE was able to provide passive protection (Ogilvie and
Jones, 1971). Complement levels do not change during the infection, and the course
of the infection is unaltered by depletion of complement by treatment with cobra
venom factor (Ogilvie and Jones, 1973). Antibody treated worms do not take up
inorganic phosphate from the host, have an altered production of secretory enzymes,
and have severe degenerative changes in the cytoplasm of their gut cells (Ogilvie and
Jones, 1973). This evidence suggests that antibody may interfere with the metabolism
of the parasite by inhibition of feeding.
Although these worms are damaged, antibody alone is not sufficient to cause
expulsion of the worms. It is now clear that these damaged worms do not simply
leave the host, but they are expelled by a further active process. This analysis is
supported by the fact that even though damaged worms are quickly expelled from
normal adult rats, they are not expelled by neonatal rats, irradiated adult rats, or
even by irradiated rats which are passively immunized with protective antiserum
(Ogilvie and Jones, 1971).
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Once it was understood that the second step of expulsion was an active process
that was destroyed by irradiation and not restored by antibodies, mast cells were
investigated as the essential second step.

These studies demonstrated that

remarkably high numbers of mast cells accumulated in the jejunal mucosa of the host
during Nb infection. These mast cells have been shown to be thymus-dependent
(Olson and Levy, 1976), and this accumulation could be supported by adoptive
transfer of lymphocytes from Nb-infected animals (Nawa and Miller, 1979). Although
mast cells appear to be functionally active during the expulsion process (Woodbury
et al., 1984; Baird et al., 1985; Cheema and Scofield, 1985) they do not appear to be
an essential part of the defense against Nb as evidenced by the fact that adult worms
can be eliminated normally by mice which are deficient in mast cells (Uber et al.,
1980; Crowle and Reed, 1981; Mitchell et al., 1983).
In agreement with data from other helminth infections (Riedlinger et al., 1986;
Urban et al., 1984), it is now clear that sensitized T cells, not mast cells, cause the
final expulsion of worms. This is supported by data which shows that damaged
worms can be expelled by irradiated rats when these rats are given mesenteric lymph
node cells from uninfected syngenetic donors. Also, rats given sensitized lymphocytes
rapidly expel worms which have been damaged by antibodies, but these same rats
expel normal worms much more slowly (Ogilvie and Jones, 1973; Ogilvie and Jones,
1971). One can therefore conclude that sensitized T cells do not act on the parasite
until it has been damaged by antibody.
Nonetheless, the fact remains that a remarkable mastocytosis develops in Nb
infected rodents, and this fact has been capitalized on by investigators who are
interested in the origin of mast cells (Befus and Bienenstock, 1979; Guy-Grand et
al., 1984), their immunologic properties (Lee et al., 1982), and the mediators that
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they release during an immune response (Woodbury and Miller, 1982; White and
Pearce, 1982; King and Miller, 1984; Miller et al., 1983; King et al., 1986; Befus et
al., 1979). In the early 1980's, several laboratories began to expand mast cells from
Nb infected animals in vitro using a source of IL-3 as the growth factor (Denburg et
al., 1980; Haig et al., 1982; Abbud-Filho et al., 1983; Haig et al., 1984), and mast
cells produced in this manner have been functionally characterized (Shanahan et al.,
1986).
The details of how antibody mediated damage of adult worms makes them
susceptible to the effects of sensitized T cells is not clearly understood. Mackenzie
and his colleagues have shown an interaction of eosinophils, neutrophils,
macrophages and mast cells with the surface of Nb in vitro in the presence of Nb
specific antibodies or complement (Mackenzie et al., 1981). In these experiments,
mast cells adhered to Nb for only four to six hours, did not flatten onto the worm
surface, and did not degranulate. Eosinophils adhered within minutes to the surface
of worms, flattened and degranulated; thus, only their cytoplasmic remnants could
be seen on the worms' surface after 24 hours. In contrast, only a small area of the
cell membrane of neutrophils flattened onto the worm surface, and adherence ceased
after two to twenty-four hours. Macrophages adhered permanently to the surface of
worms, but they did not flatten. These macrophages exhibited fewer granules and
an increased number of vacuoles later in the culture period.

However, the

importance of these in vitro findings may be limited, because although there is a
remarkable inflammatory reaction in the lamina propria in vivo, and worms are
attached to cells deep within the crypts in proximity to that inflammation, the worms
do not have lymphocytes or any other cells actually adhering to them (Mackenzie et
al., 1981).
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Sensitized T cells are thought to bring about the second stage of the expulsion
process through the release of non-specific factors acting on mucus secreting goblet
cells in the intestinal epithelium (Nawa and Korenaga, 1983). It may be important
to note that the numbers of goblet cells in the jejuna! epithelium and the amount of
total mucus secreted increase proportionally to the total worm burden. This increase
in mucus may act to coat damaged worms and prohibit their adherence to gut
epithelial cells. During this increase in mucus production, T cells located in the
mesenteric lymph node and spleen are known to be active (Bloch et al., 1977), and
severely T cell-depleted rats not only fail to produce the mastocytosis, but also can
not clear the infection (Mayrhofer and Fisher, 1979). Interestingly, moderately T
cell-depleted rats or rats that had undergone the surgical removal of their mesenteric
lymph nodes, spleen, or Peyer's patches show no adverse effect on the ability of the
host to generate the mastocytosis or to clear the infection (Heatley et al., 1982).
Thus, it appears that the T cell depletion must be complete for the adverse effects
to be manifested.
Although the exact mechanism of the T cell effect remains unclear, it is likely
that T cells act as important coordinating cells to control the progress of the immune
response by several mechanisms (in addition to increasing mucus production)
including: [1] interacting with B cells and providing B cell help via the production
of soluble mediators such as IL-4 which is required for these cells to undergo
blastogenesis (Howard et al., 1982) and eventual differentiation into primarily IgG
or IgE producing plasma cells (Coffman et al., 1986), [2] producing higher levels of
IL-3 which is thought to cause the proliferation of mucosal mast cells at the site of
the immune response (Abbud-Filho et al., 1983), [3] the releasing of an eosinophil
stimulation promotor (Newlands et al., 1984), and [4] the eventual down regulation
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of the immune response by the production of interferon-gamma which has been
shown to dramatically slow the proliferation of mast cell progenitors in vitro (Huff
and Justus, 1988) and the down regulation of the expression of Ia on the surface of
B cells (Mond et al., 1986).
Another well studied phenomenon which occurs in Nb-infected rodents is the
remarkable spike in IgE production (Ishizaka et al., 1976; Ishizaka et al., 1976a;
Allan and Mayrhofer, 1981; Befus et al., 1982). Virtually all B cells in the mesenteric
lymph node of Nb-infected mice have low affinity lg receptors on their surface
(Urban et al., 1984), and the function of these receptors is unknown. There is also
evidence that the parasite itself may be potentiating a non-specific IgE response
(Urban, 1982), thus some of this increase in IgE is thought to be due to antigens
released from the parasite which act as polyclonal activators for B cells. Nonetheless,
the benefit of the increased production of the parasite specific portion of the IgE
response may be important. Nematodes, cestodes, and trematodes all stimulate the
production of the IgE response whereas protozoan parasites generally do not.
Whatever the functional purpose of the IgE spike may be, researchers have
taken advantage of the response to Nippostrongylus to study the immunological
mechanisms supporting IgE production (Urban and Ishizaka, 1978; Urban et al.,
1978; Suemura et al., 1978; Katona et al., 1983), particularly in the areas of IgE
binding factors (Suemura and Ishizaka, 1979; Ishizaka, 1984; Ishizaka, 1983; Huff,
1988), the effect of aging on immunoglobulin production (Turner et al., 1981), and
the genetics of isotype switching (Katona et al., 1985). So it is clear that the focus
of research which is directed at the two most remarkable responses of the host (i.e.
mastocytosis and IgE spike) has drifted away from the role of these responses in host
protection, and most laboratories have refocused on using these dramatic responses
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as a powerful tool in the study of lgE production and mast cells themselves.

The use of mast cell-deficient mice in mast cell research
Mast cell-deficient mice have been widely used in the study of mast cell biology,
especially in the areas of origin, differentiation, and function, as has been noted in
several reviews (Nakano et al., 1986; Galli and Kitamura, 1987; Nakano et al.,
1987b). The Kitamura group were the first to describe the lack of mast cells in
W /W mice (Kitamura and Hatanaka, 1978) and in Sl/Sld mice (Kitamura and Go,
1979). The genetics of the defect in these mice were summarized in a 1979 review
by Russell (Russell, 1979).
The W and SI loci are both highly mutable.

The W mutation has been

incorporated in old fancy stocks, and the W occurred in the C57BL strain at the
Jackson Laboratory before 1937. The Sl mutation arose in the C3H strain at the
Oak Ridge National Laboratory before 1956, and the Sld mutation arose in the
DBA/21 strain at the Jackson Laboratory before 1960. These four semi-dominant

mutations have similar effects on hair pigmentation, fertility, anemia, and viability.
Heterozygotes W/+, W / +, SI/+, and Sld/+ have identifying white spots and some
dilution of pigment; however, they are fertile, not anemic or slightly anemic, and
have normal lifespans. In contrast, homozygotes or animals with two mutated alleles
(W/W, W/W, W/W, Sl/Sl, Sl/Sld, and Sld/Sld) are white with black eyes, severely
anemic, sterile, lack both subsets of mast cells, and except for the W/W, die early
in life. To produce the mice that are useful in mast cell studies, WB/ReJ-W/+ are
crossed with C57BL/6J-W/+ mice to produce the WBB6FifJ generation which
includes four kinds of mice: W/W, W/+, W/+, and +/+. A parallel sequence of
matings leads to the WCB6FJJ Sl/Sld generation.
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Although W/W mice have a mast cell defect at the level of the bone marrow
(Kitamura and Hatanaka, 1978), when normal bone marrow progenitors are injected
into the mouse, they differentiate normally. Thus W/W mice represent a normal
environment for the study of mast cell heterogeneity and differentiation as reviewed
earlier. In addition, because of their mast cell deficiency, W/W mice have been
widely used in studies designed to determine the functional role of mast cells in
immunological responses. With the exception of their inability to produce the
mastocytosis associated with intestinal parasite infection (Crowle, 1983; Uber et al.,
1980; Crowle and Reed, 1981; Mitchell et al., 1983), the immune responses of W/W
mice to most types of challenges appear to be essentially normal. W/W mice clear
a primary Nb infection normally (Uber et al., 1980), or somewhat slower (Crowle and
Reed, 1981) than normal mice, and clear subsequent Nb infections as quickly as
normal mice (Crowle and Reed, 1981). W/W mice also have a normal contact
sensitivity response (Ha et al., 1986; Mekori and Galli, 1985), and they exhibit
normal delayed hypersensitivity responses (Ha et al., 1986; Mekori and Galli, 1985).
Also, W /W mice have a normal antibody response to a variety of antigens (Ha et
al., 1986). These mice do have a decreased anti-tick response which can be reversed
by injecting cultured mast cells into a section of skin. Sl/Sld mice have not been as
widely used in these types of functional studies, but because their defect is at the
level of the connective tissue microenvironment (Hayashi et al., 1985), these mice
have been very valuable in the study of mast cell differentiation (Galli and Kitamura,
1987). Although the location of each mutation is known (chromosome 5 for W/W
and chromosome 10 for Sl/Sld), the gene product of each of the normal alleles has
not been identified (Galli and Kitamura, 1987).

Materials and Methods

Mice. Female BALB/c mice were obtained from Dominion Laboratories (Dublin,
VA). WBB6F 1 /J mice with genotypes W/W, W/ +, W/ + and +/ + were purchased
from The Jackson Laboratory (Bar Harbor, ME). WCB6Fi/J mice with genotypes
Sl/Sld and +/ + were also purchased from The Jackson Laboratory. All mice were
used at eight to ten weeks of age.
Infection with Nippostrongylus brasiliensis. Nb was maintained as described by others
(Befus et al., 1979). To obtain the MCCP, mice were infected with Nb by a single
subcutaneous injection of 800-1,000 L3 infective larvae and were sacrificed at day 14
after infection. Their mesenteric lymph nodes were removed, and a single cell
suspension was prepared from their Nb-MLN and washed twice. Viable cells were
enumerated by automated counting (Coulter Electronics Limited, Luton, England),
and the percentage of viable cells was determined by their ability to exclude trypan
blue, a vital dye. The majority of the cells were determined to be lymphocytes by
fluorescence microscopy after staining for surface immunoglobulin or Thy-1. The
production of MCCP is illustrated schematically in Figure 1.
Fibroblast cell lines. The contact inhibited murine fibroblast cell line BALB/31'3
clone A31 and Cl.7 as well as the non-contact-inhibited L929 fibroblast cell line
were all obtained from American Type Culture Collection (Rockville, MD).
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Figure 1.

Production of MCCP. This figure is a schematic representation of the
production of the MCCP as described in the Materials and Methods.
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Cell surface markers of murine mast cell heterogeneity. A panel of three rat
monoclonal antibodies (Stevens et al., 1987) that recognize murine cell surface
markers of mast cell heterogeneity was a kind gift of Dr. H. R. Katz, Havard Medical
School (Boston, MA). This panel included affinity purified immunoglobulin from the
hybridomas Bl.1, B24.1, and B54.2.
Preparation of embryonic skin monolayers. Trypsinates of murine embryonic skin
were obtained as previously described (Huff et al., 1980), and cells were subcultured
at low density to deplete the numbers of trypsin-resistant adherent cells (Huff et al.,
1980) and mast cells associated with the embryonic skin. All cell cultures were done
in Dulbecco's modified Eagles medium (Hazelton Research Products, Denver, PA)
which had been supplemented with 1% l-glutamine, 50 µg of gentamicin per ml, 1%
penicillin-streptomycin solution, and 10% fetal calf serum (cDMEM), all of which
were obtained from Gibco Laboratories ( Grand Island, NY). Where indicated,
monolayers were prepared from the fibroblast cell lines 3T3, L929, or Cl.7.
Preparation of mast cell cultures. A single cell suspension of Nb-MLN was prepared
from mice 14 days after infection with Nb, and the cells were seeded onto
monolayers of embryonic skin at a concentration of 5xla5 per cm2 in 35 mm tissue
culture dishes (Costar, Cambridge, MA). After two hours of incubation at 37 ° C, the
cells which were not able to associate with the monolayer were flushed away by
vigorous pipetting, and the monolayers and associated cells were cultured for 11 days
in cDMEM. Monolayer intercalation of MCCP is illustrated schematically in Figure
2. The medium was changed every two days by aspirating most of the spent medium
and replacing it with an equal volume of fresh medium. After 11 days, the mast cells
were enumerated by air drying and staining the monolayers for one hour with 0.2%
toluidine blue in 50% ethanol adjusted to pH 2.8 with 0.1 M citric acid. Mast cells
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Figure 2.

Monolayer intercalation of MCCP. This figure is a schematic
representation of the monolayer intercalation of MCCP as described
in the Materials and Methods.
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were then counted in three sets of five random fields at a magnification of 400x.
Depletion of T cells from preparations of Nb-MLN. In some experiments, T cells
were depleted from the Nb-MLN by complement mediated cytotoxicity. Anti-Thy1.2 and anti-Lyt-1 (both from Cedarlane Laboratories, Hornby, Ontario) were added
to a single cell suspension of Nb-MLN at an appropriate dilution for 40 minutes at
4 ° C. Cells were washed and then incubated with a 1:12 dilution of low-toxicity
°

rabbit complement (Cedarlane Laboratories) at 37 C for 45 minutes. Efficiency of
T cell depletion was determined by fluorescence staining for Thy-1.2 + cells and only
2 to 10% of remaining cells were Thy-1.2 + .
Staining of seeded monolayers for T cells and B cells. During the preparation of
mast cell cultures, some of the monolayers were stained for the presence of lymphoid
cells after the cells which had not intercalated into the monolayer had been flushed
away. Some monolayers were stained at day O while others were stained after 11
days of culture. T cells were identified by staining with rat-anti-mouse Thy-1.2
(Jackson ImmunoResearch Laboratories, Avondale, PA) at 1 µg per ml for 30
minutes and then washing three times in phosphate buffered saline which had been
supplemented with 10 mM sodium azide. The second antibody was a fluorescein
labelled F(ab)' 2 mouse anti-rat lg (Jackson ImmunoResearch Laboratories). Some
monolayers were stained separately for B cells in a one-step procedure using FITC
labeled goat-anti-mouse lg.
Preparation of exosecretory antigen. Exosecretory antigen from Nb was prepared by
methods previously described by Bloch et al. (Bloch et al., 1977). Briefly, 250 gram
male rats were infected subcutaneously with 2,800 infective larvae, and adult Nb were
collected from the jejunum at day eight after infection. Adult Nb (150 per ml) were
cultured for two days at 37 ° C and 5% CO2 in RPMI 1640 (Hazelton Research
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Products, Denver, PA) which had been supplemented with 1% /-glutamine, 50 µg of
gentamicin per ml, and 1% penicillin-streptomycin solution (all obtained from Gibco
Laboratories, Grand Island, NY) as well as 5x10-s M 2-ME. After culture, the
supernatant was removed, centrifuged, filter sterilized, and stored at -20 ° C until used.
The protein concentration was determined to be 0.02 mg per ml by the Lowry
method.
Berberine stain. Heparin-containing granules were identified by staining with the
fluorescent stain berberine sulfate (Sigma Chemical Co., St. Louis, MO) by the
method of Enerback (Enerback, 1974). Briefly, a 0.2% stock solution was prepared
in deionized water, and a 0.02% working solution was prepared in 0.1% citric acid
from that stock. Cells were stained for 15 minutes at room temperature then
observed for yellow fluorescence.
Lymphocyte proliferation assay. To assess the time of peak activity in the mesenteric
lymph node, a single cell suspension of mesenteric lymph node cells was prepared in
RPMI 1640 which had been supplemented as previously described plus 10% fetal calf
serum (cRPMI). Cell suspensions were adjusted to 5xl06 cells per ml, and 0.1 ml
samples were placed in wells of 96-well tissue culture plates (Costar, Cambridge,
MA).

Quadruplicate wells received either 0.1 ml of medium or dilutions of

exosecretory antigen. The cultures were incubated at 37 ° C in a 7% CO2 atmosphere
for 48 hours. One microcurie of [3H]TdR, 5 Ci per mmol (ICN Radiochemicals,
Irvine, CA) was added to each well for the final six hours of culture. Incorporated
radioactivity was determined after cells were harvested onto glass fiber strips. Data
were expressed as counts per minute (cpm) or as stimulation indexes which were
calculated by dividing the cpm of antigen stimulated cultures by those that received
only medium.
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Assay for IL-3. To assess the level of IL-3 that was being produced in the mesenteric
lymph node of Nb infected mice, supernatants from various days after infection were
generated by culturing 0.1 ml mesenteric lymph node cells which had been adjusted
to 107 cells per ml with either 0.1 ml of medium or 0.1 ml of exosecretory antigen to
yield a final concentration of 0.25 µg of protein per ml. Cells were cultured in
cRPMI for 48 hours at 37 • C, then these primary culture supernatants were removed
and stored at -20 · C until use. These primary culture supernatants from each time
point were assayed for IL-3 using the IL-3 dependent cell line DA-3 (Ihle et al.,
1984) which had been kindly provided by J. Ihle (Frederick Cancer Research Facility,
Frederick, MD). DA-3 cells were maintained in cRPMI which was supplemented
with 25% WEHI-3 conditioned medium and were transferred to cRPMI without
WEHI-3 conditioned medium sixteen hours before use. To determine the level of
IL-3 present in the primary culture supernatants, DA-3 cells (4xla3 cells per well)
were cultured for 24 hours with dilutions of the primary culture supernatants from
each time point. At six hours before the termination of culture, each well was pulsed
with 1 µCi of [3H]TdR and harvested as described for the lymphocyte proliferation
assay. Although IL-3 dependent cell lines are responsive primarily to IL-3, they are
also known to be sub-maximally stimulated by GM-CSF. Because supernatants from
Nb-MLN at peak time periods supported DA-3 proliferation equal to an IL-3 positive
control (WEHI-3 conditioned medium), the majority of the response is attributable
to IL-3. Nonetheless, augmentation of the response by GM-CSF cannot be ruled out.
Assay for interferon. The same Nb-MLN primary culture supernatants which were
assayed for IL-3 were also assayed for interferon by the method of Vogel et al.
(Vogel et al., 1986) which tested their ability to protect a fibroblast monolayer from
the cytopathic effect of vesicular stomatitis virus. This assay measures all types of
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interferon; however, because these primary culture supematants were generated
mainly from blasting T cells, one would expect the interferons present to be mostly
gamma interferon. Dilutions of primary culture supematants were made in cRPMI,
and 0.1 ml samples were placed in 96-well plates. L929 fibroblasts were adjusted to
2xla5 cells per ml in RPMI which was supplemented as previously stated except that
the fetal calf serum was supplemented at only 1%. A 0.1 ml volume of L929
fibroblasts was added to each well and incubated 24 hours at 37 ° C in a humidified
atmosphere of 5% CO2 in air. Each assay included three controls: 1) cells incubated
with dilutions of a known concentration of interferon, 2) cells with no interferon to
which was added no virus, and 3) cells with interferon to which virus was added.
After the 24 hour incubation, the contents of each well were poured off and each
well was rinsed twice with warm medium. Each well was inoculated with 0.1 ml of
vesicular stomatitis virus which had been titered and diluted to yield a multiplicity
of infection of about 0.1. This amount of virus was chosen because it is twice the
amount of virus required to produce complete cytopathic effect in unprotected cells.
The plate was incubated another 48 hours until the cytopathic effect was complete
in unprotected wells. After incubation, the contents of each well were again poured
off and the wells were washed with cold phosphate buffered saline (pH 7.4) to
remove dead cells and debris. The remaining cells were fixed with 5% formaldehyde
for 30 minutes, the formaldehyde was poured off, and the plate was air dried. Each
well was stained with 0.05% crystal violet for 30 minutes, and the plates were washed
well with tap water and air dried. The crystal violet which remains in the well is
proportional to the number of fibroblasts which were protected from the virus thus
remaining attached to the bottom of the well. The crystal violet was eluted from the
remaining fibroblasts in each well with 100 µl of methanol, and the OD570 of each
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well was determined on a standard plate reader for enzyme-linked immunoabsorbent
assays.
Cytokines. Purified IL-3 and GM-CSF were purchased from Genzyme, Inc. (Boston,
MA), as preparations which had been purified from serum-free supernatants of
LBRM-33-5A4 cells by ion exchange chromatography and HPLC. IL-3 was also
obtained as a conditioned medium from the cell line WEHI-3. Conditioned medium
from WEHI-3 cells is free of other known colony stimulating factors (Lee et al.,
1982). Murine rIL-4 and human rIL-la was also purchased from Genzyme. Murine
rIFN-.., (Gray and Goedde!, 1983) was a gift from Genentech (San Francisco, CA).
Murine IFN-a,B was purchased from Lee Biomolecular (San Diego, CA), as a
preparation which was purified by ion exchange chromatography and HPLC from a
fibroblastoid line.

Purified IL-2 from JURKAT cell line was a gift from the

Biological Response Modifiers Program (Frederick, MD), and human rIL-2 was a gift
from Cetus Corp (Emeryville, CA). Purified murine epidermal growth factor was
purchased from ICN ImmunoBiologicals (Lisle, IL) as a purified preparation from
submaxillary glands of adult mice. Recombinant human tumor necrosis factor
(rTNF) and human rG-CSF (Amgen Biologicals, Thousand Oaks, CA) are factors
with known biological activity in the mouse. Nerve growth factor (NGF) was a kind
gift of Jean Marshall, Ph.D., McMaster University (Hamilton, Ontario) and was
isolated from the submaxillary glands of male mice by the method of Mobley et al.
(Mobley et al., 1976). It was purified to homogeneity by affinity chromatography
using monoclonal anti-NGF (Beta-1 clone) on Sepharose 4B.

The final NGF

preparation was biologically active in a neurite outgrowth assay and ran as a single
band on SDS-PAGE and as a single peak on an HPCL TSK 3,000 column. No
epidermal growth factor contamination could be detected using an ELISA technique.
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NGF was also purchased as a purified preparation from Collaborative Research
Incorporated (Bedford, MA). Both NGF preparations were 2.SS. Purified human
fibronectin was purchased from Cappel (West Chester, PA), and affinity
chromatographically purified murine serum fibronectin was purchased from
Biomedical Technologies Inc. (Stoughton, MA). M-CSF was concentrated from the
supernatant of murine L929 fibroblasts. Potencies of all colony stimulating factors
were confirmed in bone marrow cultures, IL-2 supported proliferation of an IL-2
dependent cell line, and efficacy of IFN was confirmed by the ability to protect L929
fibroblasts from the cytopathic effect of vesicular stomatitis virus.
Preparation of conditioned medium from pokeweed mitogen-stimulated spleen cells
(PWM-CM). PWM-CM was prepared by stimulating 2xl06 BALB/c nucleated spleen
cells per ml with 3 µg per ml pokeweed mitogen in cRPMI by the method of
Nakahata (Nakahata et al., 1982). PWM-CM was harvested at day seven and was
centrifuged at 800 x g before being stored at -20 ° C. PWM-CM has been shown to
be a rich source of both IL-3 and IL-4 (Hamaguchi et al., 1987).
Proteoglycans and glycosaminoglycans. Murine heparin was purified from rat mast
cell granules (Schick et al., 1984) and was a gift from L. Schwartz, M.D., Ph.D.,
Medical College of Virginia (Richmond, VA). Chondroitin sulfate A (from whale
cartilage) and hyaluronic acid (from human umbilical cord) were purchased from
Sigma Chemical Co. (St. Louis, MO). Chondroitin sulfate B (from pig skin),
chondroitin sulfate C (from shark cartilage) and keratan sulfate were purchased from
Miles Scientific (Napierville, IL).
Preparation of fibroblast conditioned medium (F-CM). F-CM was produced by
culturing BALB/3T3 clone A21 fibroblasts (obtained from ATCC, Rockville, MD)
or monolayers produced from trypsinates of murine embryonic skin (Huff et al.,
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1980) in cDMEM. After 5-7 days of culture, conditioned supernatant was removed,
centrifuged at 600 x g, and then concentrated 10 to 50-fold using an Amicon
ultrafiltration unit (Amicon Corporation, Danvers, MA) employing a Diaflo YM5
membrane. Because the embryos of mast cell-deficient mice cannot be distinguished
from their littermates, fibroblast monolayers from mast cell-deficient mice and their
normal littermates were prepared from adult mice as described below.
Unconditioned cDMEM was similarly concentrated for the media control.
Preparation of F-CM from monolayers of murine skin connective tissues of mast
cell-deficient mice and their littermates. Monolayers were prepared from skin
connective tissues of mast cell-deficient mice and their littermates using an air pouch
technique. Mice were sacrificed and 5 ml of air was injected subcutaneously on the
dorsum using a 26 gauge needle. The skin was then incised and reflected, and the
loose connective tissue making up the air pouch as well as surrounding connective
tissue was removed. Tissues were minced with scissors and then digested with trypsin
for 45 minutes at 37 ° C. After trypsinization, undigested tissues were removed, and
the remaining cells were washed and plated in a 25 cm2 tissue culture flask in
cDMEM. By phase contrast microscopy, these monolayers appear to be primarily
composed of fibroblasts, although a small percentage of cells could be one of several
other cell types. F-CM was prepared by harvesting the supernatant from a confluent
monolayer after seven days of culture. This conditioned medium was centrifuged to
remove cell debris and then concentrated ten-fold using an Amicon ultrafiltration
unit (Amicon Corporation, Danvers, MA) employing a Diaflo YM5 membrane.
Partial purification of F-CM. When indicated, the proteins in concentrated F-CM
were separated using sequential ammonium sulfate precipitations at 50, 60, 70, and
80% saturation. The supernatant from each precipitation was subjected to the next
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higher level of saturation, whereas the precipitate was resuspended in distilled water
and desalted by dialyzing for 48 hours at 4 ° C against three changes of phosphate
buffered saline. To separate the proteins in F-CM by size, Amicon ultrafiltration was
conducted under high salt conditions by adding NaCl to lx F-CM to bring it to 1.5
M NaCl, and then sequentially filtering with a YMlOO and a XM50 membrane
before concentrating over a YM5 membrane. Concentrates from each filter size
were dialyzed before use. The quality of separation was determined by HPLC with
a size exclusion column (GPC 300, SynChrom, Inc., Lafayette, IN).
Separation of F-CM by size exclusion chromatography. Fractionation of 3T3 F-CM
by size exclusion chromatography was conducted over a Sephadex G-75 column
(Pharmacia, Piscataway, NJ) with a bed volume of 95 cm at 4 ° C under high salt
conditions (1.5 M NaCl buffered with 20 mM HEPES). The flow rate was 0.1 ml per
minute.

I-labeled chymotrypsinogen (25 kD) was included in each run as an
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internal column calibration control. Samples were dialyzed against RPMI 1640
before use in biological assays. Each fraction was monitored for protein content by
taking readings at OD280 •
Enzyme digestion of F-CM. Amicon concentrated F-CM was incubated with six
units of insoluble trypsin or ten units of insoluble chymotrypsin which was bound to
°

beaded agarose (Sigma Chemical Co., St. Louis, MO). Following incubation at 37 C
for one hour, the beads were removed by centrifugation for 10 minutes at 800 x g.
Absorption of NGF from F-CM. Where indicated, NGF was removed from F-CM
by affinity chromatography using an excess of an ammonium sulfate precipitated
polyclonal antibody or monoclonal anti-NGF (Beta-1 clone). NGF was eluted from
affinity columns with glycine HCl at pH 2.8 and was dialyzed against phosphate
buffered saline before use. F-CM absorbed with either polyclonal or monoclonal
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anti-NGF did not support neurite outgrowth.
Production of a rabbit antiserum to IL-3. A peptide consisting of the 16 N-terminal
amino acids (Asp-Thr-His-Arg-Leu-Thr-Arg-Thr-Leu-Asn-Cys-Ser-Ser-Ile-Val-Lys)
from the publishoo sequence for IL-3 (Yokota et al., 1984) was synthesized and
coupled to a carrier protein by the Peptide Synthesis Laboratory, Institute of
Biotechnology, Virginia Center for Innovative Technology (Richmond, VA). The
peptide was assembled by conventional Merrifield Solid Phase technology
(Merrifield, 1986; Merrifield, 1985) and was removed from the resin by reaction with
a hydrogen fluoride/methyl ethyl sulfide/anisole mixture. The crude peptide was
purified by preparative HPLC using a Partisil ODSl0-3 Magnum 20-50 column. The
major peak was detected at 220 nm and was determined to be 98% pure by analytical
HPLC.
Two 1mmunogens were prepared from this peptide usmg the methodology
outlined by Yoshitake (Yoshitake et al., 1979) for the preparation of antibody
enzyme conjugates. The presence of cysteine in the peptide allowed us to use the
side chain thiol group as a selective and convenient handle for attachment to keyhole
limpet hemocyanin or bovine serum albumin. N-succimidyl-4-(N-maleimidomethyl)
cyclohexane-l-carboxylate (SMCC), which is classified as a heterobifunctional
crosslinker, reacts specifically with amino groups in proteins via its activated ester
moiety. In this way, maleimido groups were introduced into the protein. The former
species reacts smoothly with thiol groups to form stable thioester bonds. Following
the chemical reactions, each immunogen was dialyzed extensively against distilled
water and lyophilized. Analytical HPLC was used to measure the disappearance of
the IL-3 peptide during the course of the reaction. Based on these data and the
stoichiometric amounts of the starting materials, we have ascertained an approximate
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substitution value for bovine serum albumin of 38: 1 with respect to the
peptide:protein ratio. For the preparation of the keyhole limpet hemocyanin-peptide
conjugate, 5 mg of activated keyhole limpet hemocyanin consumed 4 mg of IL-3
peptide, suggesting an efficient coupling was accomplished.
Two New Zealand White rabbits were immunized intramuscularly with 100 µg
IL-3 peptide-keyhole limpet hemocyanin conjugate emulsified in Complete Freund's
Adjuvant and continued immunizations were conducted with 100 µg conjugate in
phosphate buffered saline by intravenous injection every four weeks. Rabbits were
bled two weeks after each injection and the serum was precipitated with 33%
saturated ammonium sulfate. The anti-IL-3 titre of the precipitated antibody was
determined in an enzyme-linked immunoabsorbent assay as described in the next
paragraph. The results (Table 2) demonstrate that the anti-peptide antibody can be
detected at a dilution of 1:16,384. Functional assays demonstrated that the antiserum
did not directly inhibit the biological activity of the native IL-3 molecule; therefore,
the anti-IL-3 was coupled to Affi-gel active ester agarose (Bio-Rad, Richmond, CA)
at 20 mg antibody per ml of packed beads. Optical density readings indicated that
the coupling procedure was 95% efficient. Human serum albumin was similarly
coupled as a control. In functional assays using an IL-3 dependent cell line, affinity
chromatography procedures using the fixed antibody was found to absorb greater
than 500 units IL-3 per ml from a starting preparation of 1,000 units IL-3 per ml
(P=.004) as shown in Table 3.
Enzyme-linked immunoabsorbent assay. An enzyme-linked immunoabsorbent assay
(Voller et al., 1988) was used to measure the amount of specific anti-IL-3 antibody
in the ammonium sulfate precipitated preparation which had been prepared from the
serum of hyperimmune rabbits. Wells of a microtiter plate were coated with 50 µ.l
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Anti-IL-3 hyperimmune serum binds the immunizing peptide

Table 2. Anti-IL-3 hyperimmune serum binds the immunizing peptide. Anti-IL-3 hyperimmune serum
was produced in rabbits by immunization with a synthetic peptide representing the N-terminal sequence
of IL-3 which had been coupled to keyhole limpet hemocyanin as a carrier protein. The hyperimmune
serum was subjected to a 33% ammonium sulfate precipitation to partially purify the IgG fraction. This
preparation was serially diluted into wells which had been coated with 1 µg per ml of a bovine serum
albumin-peptide conjugate, and a standard enzyme-linked immunoabsorbent assay was conducted using
the enzyme alkaline phosphatase and pNPP as the substrate. Data is shown as the value of the OD410
± standard deviation for triplicate wells.
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Removal of IL-3 by affinity chromatography

Table 3. Removal of IL-3 by affinity chromatography. Purified IL-3 (1,000 units per ml) was subjected
to affinity chromatography over active ester agarose beads which had been reacted with either 20 mg
per ml of partially purified lgG from anti-IL-3 hyperimmune rabbit serum or 20 mg per ml of human
serum albumin. Dilutions of effluent from each column as well as unabsorbed IL-3 were used to
support proliferation of the IL-3-dependent cell line DA-3. In a 24 hour assay, DA-3 cells were cultured
at 3xl04 cells per well in a 96-well plate. Cultures were given a terminal six hour pulse with 1 µCi of
[3H]TdR and incorporated radioactivity was measured by liquid scintillation counting. Data is shown
as cpm ± standard deviation of quadruplicate wells and demonstrates that about 50% of the IL-3 was
specifically absorbed (p= .004).
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of a conjugate of the IL-3 N-terminus peptide-bovine serum albumin which had been
adjusted to 1 µg protein per ml in borate buffered saline (see Appendix for
formulation of all reagents). Plates were stored overnight at 4 ° C and then washed
three times with 100 µl per well of Tris-buffered saline. The last wash was allowed
to stand five minutes before aspirating. Each well was then blocked by pipetting 100
µl per well of a blocking buffer containing 3% bovine serum albumin and incubating
the plate at 25 ° C for two hours. After washing the plate three times in Tris-buffered
saline which had been supplemented with Tween 20 (TTBS), 50 µl per well of
various dilutions of the anti-IL-3 antibody were added to each well and the plate was
incubated at 25 ° C for 45 minutes. The plate was washed four times with TTBS
before the labeled second antibody was added. This labeled antibody was an alkaline
phosphatase

conjugated

affinity

purified

goat-anti-rabbit

IgG

(Jackson

ImmunoResearch, West Grove, PA) which had been diluted 1:5,000 in Tris-buffered
saline. After incubating 45 minutes at 25 ° C (50 µl per well), the plate was washed
four times in TIBS. The alkaline phosphatase substrate pNPP was dissolved in
substrate buffer to yield 1 mg per ml and 50 µ1 was added per well. After incubating
the plate for 30 minutes at 25 ° C, the absorbance of each well at 410 nm was
recorded on a standard plate reader.
Methylcellulose culture system. Methylcellulose culture was conducted usmg a
modification of the method of Pharr et al. (Pharr et al., 1987). A culture mixture
containing 2xl04 nucleated bone marrow cells, 6xla5 nucleated Nb-MLN cells or
6xla5 nucleated spleen cells, MEM alpha medium (Gibco, Grand Island, NY), 1.5%
of 4,000 centipoise methylcellulose (see Appendix) purchased from Fisher Scientific
(Fair Lawn, NJ), 30% fetal calf serum, 1 % deionized bovine serum albumin (see
Appendix), 1% /-glutamine, 50 µg per ml gentamicin, 1% streptomycin solution, and
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5xl0-5 M 2-ME was supplemented with dilutions of various factors as indicated just
before plating. Culture mixtures were plated in 35 mm petri dishes (Falcon, Becton
Dickinson Labware, Oxnard, CA) at 1.5 ml per dish and cultured for eight days
(bone marrow cells) or 13 days (mesenteric lymph node cells) at 37 ° C in 5% CO2 in
humidified air. At the termination of culture, individual colonies were enumerated
and composite cytospin slides were made by harvesting an entire plate into cold
phosphate buffered saline, washing the cells once to remove the methylcellulose,
resuspending the cells in 0.4 ml cold phosphate buffered saline, and spinning 0.2 ml
samples in a cytocentrifuge (Cytospin, Shandon Southern, Elliot, IL) at 600 rpm for
five minutes. Differential cell counts were conducted after staining with May
GrOnwald and counterstaining with Giemsa (see Appendix). The relative number
of each cell type produced in methylcellulose culture was calculated by multiplying
the total colony count of a culture times the percentage of each specific cell type
observed on the cytospin preparation. To confirm the percentage of mast cells
produced, duplicate slides were stained with 0.2% toluidine blue (see Appendix), and
the percentage of cells with metachromatic granules (mast cells) was determined.
When desired, a third slide was prepared and stained to determine the type of
proteoglycan being produced using alcian blue and counterstaining with safranin (see
Appendix). As previously stated, connective tissue mast cells are safranin positive
whereas mucosa! mast cells are alcian blue positive but negative for safranin stain
(Enerbcick, 1966a). Methylcellulose cloning of MCCP is illustrated schematically in
Figure 3.
Enrichment for MCCP in Nb-MLN. In the liquid culture experiments, Nb-MLN
were enriched for MCCP on the basis of cell density. Nb-MLN (1()8 cells per 15 ml
tube) were pelleted, the medium was removed, and the cells were overlayed with
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Figure 3.

Methylcellulose cloning of MCCP. This figure is a schematic
representation of the methylcellulose cloning of the MCCP as described
in the Materials and Methods.
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54% Percoll. Cells were centrifuged at 800 x g for 15 minutes and buoyant cells were
removed and washed twice. Cells were plated in 96-well low evaporation plates
(Costar, Cambridge, MA) at 2x1D5 cells per well in DMEM which was supplemented
with 30% fetal calf serum, 1% deionized bovine serum albumin, 1% 1-glutamine, 50
µg per ml gentamicin, 1% streptomycin solution, 5x1Q·5 M 2-ME, and dilutions of
various growth factors as indicated. After seven days of culture, all cells were given
a terminal 24 hour pulse with 1 µCi of [3H]TdR and incorporated radioactivity was
measured by liquid scintillation counting. Liquid culture of MCCP is illustrated
schematically in Figure 4.
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Figure 4.

Liquid culture of MCCP. This figure is a schematic representation of
the liquid culture of the MCCP as described in the Materials and
Methods.
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Results

T cell-depleted cultures on embzyonic skin monolayers.

Studies of mast cell

proliferation in other laboratories using various in vitro differentiation systems have
all demonstrated a requirement for the continuous presence of either T cells or the
T cell product IL-3 [see Literature Review for details]. Previous studies in our
laboratory suggested that mesenteric lymph node cells from mice hyperimmunized
with horse serum and infected with Nb might contain a unique progenitor which did
not need T cells (Huff and Justus, 1988). We suspected that the Nb infection and
not the horse serum immunization was responsible for the appearance of that
progenitor. To determine if T cells are required for the mast cell progenitors from
Nb-MLN to complete their development, T cells were depleted from Nb-MLN using
complement mediated cytotoxicity and the remaining cells were plated on monolayers
of embryonic skin.

T cell-depleted cultures yielded as many mast cells, and

sometimes significantly more mast cells (Figure 5, Experiment 1: p < 0.0002), than did
nondepleted Nb-MLN. This suggested that T cells or T cell products were not
necessary for mast cell development in these cultures and may have a suppressive
effect.
During these experiments, we observed by phase contrast microscopy that a
fraction of the Nb-MLN cells appeared to intercalate into the monolayer within the
first 30 to 60 minutes of culture. To determine the phenotype of the monolayer
57
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Figure 5.

T cell-depleted cultures yield as many mast cells as do non-T cell
depleted cultures. BALB/c mice were infected with 1,000 Nb L3
infective larvae and were sacrificed at day 14 of the infection. Nb
MLN cells were treated with appropriate dilutions of both anti-Thy1.2 and anti-Lyt-1 at 4 ° C for 40 minutes before incubating with rabbit
complement at 37 ° C for 45 minutes. Both the T cell-depleted and
nondepleted Nb-MLN were seeded onto monolayers of embryonic skin
fibroblasts at a cell concentration of 5xla5 per cm2 and were cultured
for 11 days. Medium was changed every two days. At the termination
of culture, monolayers were air dried and stained with 0.2% toluidine
blue. Data are recorded as the number of mast cells per five random
fields ± standard error.
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associated cells, whole (non-T cell depleted) preparations of Nb-MLN cells were
seeded onto monolayers of embryonic skin and allowed to incubate at 37 ° C for two
hours. During the incubation, the majority of the cells floated free in suspension and
exhibited a high refractive index, but a few cells appeared to have flattened onto or
intercalated into the monolayer and were seen as small dark cells.

After the

incubation, non-monolayer associated cells were flushed away by vigorous pipetting;
however, the intercalated cells remained. The monolayers and associating cells were
then stained for T cells or B cells using FITC labeled monoclonal antibodies, or were
stained for metachromatic cells (mast cells) using toluidine blue. The stains revealed
that there were no mast cells in these Nb-MLN seeded monolayers, and the vigorous
pipetting of the monolayers had removed all of the T cells; however, B cells were
able to associate with the monolayer (Table 4 ). The remaining monolayers and
associated cells were cultured for 11 days before staining. After the culture period,
mast cells were observed in every microscopic field (Table 4 ). The B cells seen in
the monolayer at day O did not persist in culture. Similar cultures of bone marrow
cells were not able to produce mast cells unless exogenous IL-3 was added (Table
4 ). Mast cells developed in a clonal pattern on these monolayers indicating that the
MCCP was undergoing proliferation before differentiation.
We interpret these data to mean that within the Nb-MLN is a population of mast
cell progenitors which differ from their more primitive bone marrow counterpart in
that they can complete their differentiation in vitro when supported by a monolayer
of embryonic skin. These MCCP were among the population of cells which were
able to intercalate into the monolayer. Because T cells did not intercalate into the
monolayer and were thereby completely removed by the pipetting procedure, it is
clear that the MCCP does not require T cells or T cell products such as IL-3 to
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Phenotype and Differentiation of Intercalated Cells

Table 4. Phenotype and differentiation of intercalated cells. Monolayers were prepared from trypsinates
of embryonic skin and were seeded with 5x1D5 Nb-MLN or bone marrow cells per cm2 and incubated
two hours before being flushed with fresh warm medium. Some cultures were then stained with 0.2%
toluidine blue or were examined for surface lg or Thy-1 by fluorescence microscopy while others were
phenotyped after 11 days of culture. Where indicated, bone marrow cultures were supplemented with
25% WEHI-3 conditioned medium as a source of IL-3. The 11 day bone marrow experiments were
conducted by A. Kukolja in our laboratory and are shown here for completeness. Data is expressed as
the number of cells per five random fields ± the standard deviation.
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complete its differentiation. Nb-MLN cultured in the absence of the monolayer did
not produce mast cells (data not shown). Lack of metachromatic cells immediately
after intercalation in monolayers rules out the possibility that mast cells were simply
plated out with the embryonic skin monolayer or were seeded onto the monolayer
from the Nb-MLN cells. The affinity of the MCCP for embryonic skin monolayer
has proven to be a simple and effective method for separating lymphokine-producing
T cells from the MCCP.
3T3 fibroblasts support proliferation and differentiation of the MCCP. Although the
embryonic skin monolayers consist primarily of fibroblasts, a variety of other cells
including keratinocytes, melanocytes, and macrophages are also present (Huff et al.,
1980). To rule out the unlikely possibility that the mast cell development is being
supported by low levels of IL-3 being released by one or more cell types present in
the monolayer, experiments were conducted using monolayers of 3T3 fibroblasts.
These fibroblasts were originally developed from BALB /c embryos, and it has been
shown that similar types of fibroblast lines do not produce IL-3 or IL-4 (Fujita et al.,
1988). Figure 6 and Figure 7a demonstrate that when monolayers of 3T3 fibroblasts
were seeded with Nb-MLN which had been rigorously depleted of T cells using
complement-mediated cytotoxicity (less than 2% Thy-1.2 + cells remained), more mast
cells developed than when the monolayers were seeded with whole (non-T cell
depleted) Nb-MLN. Alternatively, T cells were depleted from cultures by allowing
MCCP

to

intercalate

and

then

flushing

away

the

nonadherent cells.

Immunofluorescence procedures revealed that no Thy-1.2 + cells remained in these
cultures. The affinity of the MCCP for the 3T3 monolayer was not as strong as the
affinity for embryonic skin monolayers, thereby intercalation was not as pronounced
and a high proportion of MCCP were washed away during the flushing procedure.
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Figure 6.

Mast cell development from MCCP does not require a source of IL3. Cells of fibroblast cell lines or trypsinate of embryonic skin were
plated at 5x1D5 cells per 35 mm dish and allowed to grow to confluency.
For wholeNb-MLN, monolayers were then seeded with 5xl06 Nb-MLN
per dish and cultured 11 days changing the medium every two days.
Monolayer-associated Nb-MLN cultures were similarly seeded,
incubated for two hours, and non-adherent cells were flushed away.
No T cells remained in these cultures. T cell-depleted Nb-MLN were
seeded with a cell preparation in which T cells were depleted by
cytotoxicity using anti-Thy-1.2, anti-Lyt-1, and rabbit complement.
Fluorescence microscopy revealed that less than 2% of the remaining
cells were T cells. After 11 days of culture, all cultures were air dried
and stained with 0.2% toluidine blue. Data were recorded as number
of mast cells per five random 400x fields. Standard error is shown.
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Figure 7.

(A) Mast cell development in T cell-depleted cultures of Nb-MLN on
3T3 fibroblast monolayers. Monolayers of 3T3 fibroblasts were
prepared by seeding 5xl04 3T3 cells per cm2 and allowing them to grow
to confluency. Monolayers were seeded with Nb-MLN which had been
depleted of T cells by complement mediated cytotoxicity (less than 2%
of remaining cells were Thy-1.2 + ). Cells were seeded at 5x1D5 per cm2•
After 11 days of culture, all cultures were air dried and stained with
0.2% toluidine blue (x560).
(B) MCCP cultured on 3T3 monolayers contain heparin. Nb-MLN
were cultured on monolayers of 3T3 fibroblasts as described for Figure
3. A 0.2% stock solution of berberine sulfate was prepared in water.
From this stock a 0.02% working solution was prepared in 0.1% citric
acid. Monolayers were stained for 15 minutes at room temperature
then observed for yellow fluorescence.
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The reason for the decreased intercalation is unclear; however, it may be explained
by the fact that the 3T3 monolayer lacks the same three-dimensional aspect seen in
monolayers of embryonic skin. Nonetheless, the remaining MCCP underwent rapid
proliferation and yielded only slightly fewer numbers of total mast cells (as compared
to cultures of whole Nb-MLN) by the end of the culture period. When monolayers
of murine fibroblast lines L929 and Cl.7 were used, it was found that these lines were
very poor for both the intercalation and proliferation of the MCCP.
Berberine sulfate staining of mast cells from T cell-depleted cultures. Berberine
sulfate is a fluorescent dye that binds to the sulfate-containing polyanions in heparin
thereby causing heparin-containing cytoplasmic granules in connective tissue mast
cells to exhibit bright yellow fluorescence. Mucosa! mast cells contain little or no
heparin and therefore do not stain with berberine sulfate. To determine which type
of mast cell was produced in T cell-depleted cultures, berberine staining was
performed on 11 day cultures of Nb-MLN cells on embryonic skin monolayers in situ,
and also on mast cells which had become detached from longer term similarly seeded
monolayers of embryonic skin or 3T3 fibroblasts. In each case, mast cells from
monolayers stained positively with berberine (Figure 7b), whereas mast cells
produced by in vitro culture in the presence of IL-3 were berberine negative (data not
shown).
Time course studies on the appearance of the MCCP. To determine the role that
the Nb infection plays in the appearance of the MCCP in the mesenteric lymph node,
we harvested mesenteric lymph node cells from naive mice (day O of infection) as
well as mesenteric lymph node cells from groups of mice infected with Nb at
different time points over a 17 day period. Upon sacrificing these mice, it was
observed that the size of the mesenteric lymph node increased as the infection
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Figure 8.

Peak percentage of MCCP in Nb-MLN occurs at day 14 of the
infection. Nb-MLN were harvested at different time points during the
infection and were seeded onto monolayers of embryonic skin at 5xlo-5
per cm2• After two hours of incubation, cells not able to associate with
the monolayer were flushed away. The monolayers and remaining cells
were cultured for 11 days with medium changes every two days. Data
is shown as number of mast cells per five random 400x fields of
toluidine blue stained cultures ± standard error.
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progressed through day 14 before beginning regression at day 17. The number of
cells that were recovered per node ranged from 2xl01 cells in naive mice to 108 cells
in mice at day 14 of the Nb infection. Mesenteric lymph node cells from these mice
were seeded onto embryonic skin monolayers, and cells not able to associate with the
monolayer were flushed away as before. Figure 8 shows that the highest percentage
of MCCP can be found 14 days after infection, and that time point was used in
succeeding experiments.
Lymphocyte proliferation of mesenteric lymph node cells from Nb infected mice. To
determine the relationship between activity in the mesenteric lymph node and the
peak appearance of the MCCP, lymphocyte proliferation experiments were conducted
at each time point. The data revealed that the number of mesenteric lymph node
lymphocytes that are responsive to the antigens of Nb reaches a peak at day 11 after
infection (Figure 9).

This was particularly evident in the cultures that were

supplemented with exosecretory antigen. There was a maximum stimulation index
of 12.45 for day 11 after infection versus a stimulation index of 1.08 in the day 0
naive control. Any stimulation index greater than 2.0 in this assay was considered
a positive response. Cells taken from various lymphoid organs of naive mice failed
to respond exosecretory antigen (Table 5), and this demonstrates that the
exosecretory antigen was not directly mitogenic. Nb-MLN were found to continue
to respond to Nb antigens at 40 days after infection; however, neither thymocytes or
lymph node cells from a remote location (popliteal lymph nodes) responded to any
dose of antigen (Table 6).

Nb-MLN were found to continue to respond to

exosecretory antigen at 60 days after infection (data not shown).
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Figure 9.

Lymphocyte proliferation of mesenteric lymph node cells from Nb
infected mice. Nb-MLN were harvested at different time points in the
infection and were cultured in 96-well plates at 5x1()5 cells per well
supplemented with various dilutions of Nb exosecretory antigen as
indicated. The cultures were incubated 42 hours, then given a terminal
six hour pulse with 1 µCi of [3H]TdR. Incorporated radioactivity is
shown as cpm ± standard error.
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Lymphocyte proliferation in naive mice

Table 5. Lymphocyte proliferation in naive mice. Various lymphoid organs were harvested from naive
mice, and a single cell suspension from each was cultured in 96-well plates at 5xla5 cells per well
supplemented with various dilutions of Nb exosecretory antigen as indicated. The cultures were
incubated 42 hours, then given a terminal six hour pulse with 1 µCi of [3H]TdR. Incorporated
radioactivity is shown as cpm ± standard error.
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Lymphocyte proliferation in convalescent mice

Table 6. Lym phocyte proliferation in convalescent mice. Various lym phoid organs were harvested from
convalescent mice which had been infected 40 days earlier with Nb, and a single cell suspension from
each tissue was cultured in 96-well plates at 5xla5 cells per well supplemented with various dilutions of
Nb exosecretory antigen as indicated. The cultures were incubated 42 hours, then given a terminal six
hour pulse with 1 µCi of [3H]TdR. Incorporated radioactivity is shown as cpm ± standard error.
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Production of IL-3 by Nb-MLN cells. To assess the levels of IL-3 being produced by
mesenteric lymph node cells during a Nb infection, Nb-MLN were cultured in vitro
for two days with or without exosecretory antigen. The supernatants were then
removed and assayed for IL-3 using the cell line DA-3. Figure 10 (upper panel)
shows that IL-3 levels were significantly elevated early in the infection (days 5 and
8) and peaked at day 11 in cultures that were not supplemented with antigen. In the
cultures to which exosecretory antigen was added (Figure 10, lower panel), a similar
response pattern was observed. Taken together with the results from the time course
of lymphocyte proliferation, these data indicate that peak activity in the mesenteric
lymph node precedes, by several days, the time that the highest percentage of MCCP
can be recovered. This rise in IL-3 levels may be important for the transition of
the primitive bone marrow mast cell progenitor to the more differentiated state that
is able to produce mast cells in the absence of IL-3 on monolayers of embryonic skin
or 3T3 fibroblasts.
Production of interferon by Nb-MLN peaks at day 14 of infection.

Because

interferons are known to exert potent anti-proliferative effects on a variety of cell
types (Gidali et al., 1981; Fleming et al., 1972; van 't Hull et al., 1978; Mond et al.,
1985; Pfeffer et al., 1982), we wanted to determine if there were variations in the
levels of interferons at different time points during the Nb infection. To accomplish
this, the same primary culture supernatants which had been tested for IL-3 were also
tested for the presence of interferon. We employed an assay which tested the ability
of the supernatants to protect a murine fibroblast cell line from the cytopathic effect
of vesicular stomatitis virus. In contrast to IL-3 levels, interferon levels peaked at
day 14 of the Nb infection (Figure 11). These data are in agreement with the finding
by Huff and Justus that increased levels of interferon caused a reduction in the
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Figure 10.

Production of IL-3 by Nb-MLN cells. Nb-MLN cells from different
time points in the infection were cultured in 96-well plates at 106 cells
per well with (lower panel) or without (upper panel) 0.25 µg per ml Nb
exosecretory antigen. Nb-MLN were cultured for 48 hours, and then
these primary culture supernatants were assayed for their ability to
support the IL-3 dependent cell line DA-3. DA-3 cells were cultured
24 hours in cRPMI in the presence of dilutions of primary culture
supernatants as shown. Cultures were given a terminal six hour pulse
with 1 µCi of [3H]TdR and incorporated radioactivity is shown as cpm
± standard error. Media control was 38±7 cpm.

77

18

,----....
(J)

C

0

(J)

...c

+-'

C
'-...../

-

1:6

16

�
IS:SJ

1 :12

14

IZ2l

1 :48

12
10
8

With no Ag

1:24

is::::]

1:96

CJ

1:192

C2]

1 :384

IS2J

1 :768

6
4
2
0

18

With exosecretory Ag

16 �
,,....,__
(J)
--0
C
0
(J)
::J
0
..c

C
2
Q_
(_)

l

14�
12 �

IT

10 ,_
8

I

6
4-

T

II

IT

Days ofter infection

78

Figure 11.

Production of interferon by Nb-MLN.
The primary culture
supernatants tested for interferon were the same supernatants which
were assayed for IL-3 (Figure 10). Dilutions of primary culture
supernatant were made in cRPMI. L929 fibroblasts were adjusted to
2x1D5 cells per ml, and a 0.1 ml volume was cultured in a 96-well plate
in the presence of 0.1 ml of the two-fold dilutions of primary culture
supernatants. After 24 hours of culture, wells were decanted and rinsed
twice before being inoculated with 0.1 ml of vesicular stomatitis virus.
The virus had been diluted to yield a multiplicity of infection of about
0.1. After another 48 hours of incubation, contents of the wells were
again decanted, and the wells were washed with cold phosphate
buffered saline. The remaining cells were fixed with 5% formaldehyde
for 30 minutes, air dried, and then stained with 0.05% crystal violet for
30 minutes before being washed with tap water and air dried again.
The crystal violet was eluted from the remaining cells with 100 µl of
methanol, and the OD570 of each well was determined. Data shown is
the units of interferon per ml as determined by probit analysis of half
maximum values from the mean of triplicate cultures of five two-fold
dilutions of test supernatants. Interferon units are based on the anti
viral activity of an interferon-a;B standard.
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numbers of mast cells that develop in cultures in vitro (Huff and Justus, 1988);
thereby, these increased levels of interferon late in the infection may be instrumental
in down regulation of the rapidly developing mastocytosis.
Fibroblast support of the MCCP does not require cell-cell contact. Having previously
shown that proliferation and differentiation of the MCCP is supported in the absence
of T cells or IL-3 by coculture on monolayers of embryonic skin or 3T3 fibroblasts,
we wished to determine if the mechanism of monolayer support is through cell-cell
contact or a soluble factor released from the monolayer. To accomplish this, Nb
MLN were cloned in a methylcellulose culture system in the presence of 10% (v/v)
of lOx concentrated cell free supernatant from a monolayer of embryonic skin
fibroblasts. Figure 12 shows that nearly all colonies produced in response to the F
CM were mast cell colonies. When 3T3 F-CM was similarly concentrated, it too
supported the development of the MCCP (Figure 12). Colony size ranged from 20
to 300 cells. Similar results were observed (Figure 12) when the Nb-MLN were
cultured in the presence of PWM-CM, a rich source of IL-3 and other growth factors.
In both cases, many colonies of pure mast cells were formed whereas no colonies of
neutrophils or eosinophils and only an occasional macrophage colony were observed.
When cultures were supplemented with both PWM-CM and F-CM, the total number
of colonies did not exceed the number produced from PWM-CM or F-CM alone
(data not shown). Cloning efficiency assays demonstrated that less than 0.5% of
the Nb-MLN were cells which were able to produce a mast cell colony. When the
Nb-MLN were cultured in the presence of 10% (v/v) of lOx concentrated medium,
no mast cell colonies developed and only an occasional macrophage colony was
observed. The mesenteric lymph node cells from naive mice failed to produce
colonies in response to any added factors. We interpret these data to mean that the
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Figure 12.

Formation of mast cell colonies in methylcellulose from Nb-MLN.
BALB/c mice were infected with 1,000 Nb I.3 infective larvae and
sacrificed at day 14 of the infection. A single cell suspension was
prepared from their mesenteric lymph node and the cells were cloned
in methylcellulose at a concentration of 6x1D5 per ml using 10% (v/v)
PWM-CM, 15x F-CM from monolayers of embryonic skin, 15x F-CM
from monolayers of 3T3 fibroblasts, or 15x cDMEM as a control. After
13 days in culture, colonies were enumerated and the entire plate was
harvested. Cytospin slides were stained with May-GrOnwald/Giemsa
and differential cell counts were made. The percentage mast cells
was confirmed with 0.2% toluidine blue stain. Standard error is shown.
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MCCP is present in the mesenteric lymph node of Nb-infected but not naive mice,
and this progenitor requires an additional stimulus to support its proliferation and
differentiation. This stimulus can be exposure to PWM-CM which is known to be
a rich source of IL-3 (Hamaguchi et al., 1987), or the stimulus can be a signal in the
form of a soluble factor or factors produced by monolayers of 3T3 fibroblasts or
embryonic skin. Taken together with the recent demonstration that 3T3 fibroblasts
do not make mRNA for IL-3 or IL-4 (Fujita et al., 1988), these data indicate that the
fibroblast derived factor is not one of the currently known mast cell growth factors.
These data have been confirmed in over thirty separate experiments employing 18
different preparations of F-CM.

Preparations of F-CM from embryonic skin

monolayers produced 30 to 150 mast cell colonies per culture whereas 3T3 F-CM
generally produced 80 to 300 mast cell colonies per culture. It is important to note
that cultures supplemented with PWM-CM yielded nearly 100% mast cells. This
demonstrates that, with the exception of an occasional macrophage progenitor, the
Nb-MLN are virtually uncontaminated with hemopoietic progenitors other than mast

cell progenitors.
Anti-IL-3 absorbed 3T3 F-CM supports development of the MCCP. Although
fibroblasts are not suspected of producing IL-3, we wanted to rule out the possibility
that they may produce low levels of IL-3 which were sufficient to support the MCCP.
To accomplish this, anti-IL-3 was produced in rabbits by injection of a synthetic
peptide of the 16 N-terminal amino acids from the published sequence for IL-3
(Yokota et al., 1984). Ammonium sulfate precipitated anti-IL-3 was then used to
absorb 3T3 F-CM by affinity chromatography. Figure 13 demonstrates that the
number of mast cell colonies produced from Nb-MLN using anti-IL-3 absorbed 3T3
F-CM was not statistically different from the number of colonies produced using the
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Figure 13.

Anti-IL-3 absorbed 3T3 F-CM supports development of MCCP. Anti
IL-3 was produced in rabbits by injection of a synthetic peptide of the
16 N-terminal amino acids of IL-3 coupled to keyhole limpet
hemocyanin. IgG purified by precipitation with 33% saturated
ammonium sulfate was coupled to affinity gel beads (20 mg antibody
per ml beads) and was shown to remove greater than 500 units IL-3 per
ml from a starting preparation of 1,000 units per ml (P< 0.004). 3T3
F-CM was concentrated 30-fold and then incubated with the anti-IL3 coated beads. Effluent from the beads was used as the only source
of growth factors to clone Nb-MLN in a methylcellulose culture system.
Data are expressed as number of colonies times percentage mast cells
observed in differential cell counts from the harvested cultures. All
cultures contained greater than 88% mast cells. Standard error is
shown.
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nonabsorbed conditioned medium at either the 10% or 8% level of added factor.
Growth factors present in F-CM do not produce mast cells from bone marrow
progenitors. To determine if F-CM is able to support the growth and differentiation
of bone marrow mast cell progenitors, bone marrow cells from Nb-infected mice
were cloned in methylcellulose in the presence of 10% (v/v) lOx F-CM. Table 7
shows that no mast cell colonies were formed from bone marrow cells cultured in the
presence of F-CM; however, many colonies of macrophages, neutrophils, eosinophils
and mixed (macrophages and neutrophils) were formed. A similar response pattern
was observed when purified GM-CSF was used. In contrast, when the bone marrow
cells were cultured in the presence of an IL-3 source (PWM-CM or WEHI-3
conditioned medium), a wide array of colony types including mast cells, macrophages,
neutrophils, eosinophils, non-differentiated blast cells, and mixed colonies were
observed. Similar results were obtained when the bone marrow cells were harvested
from naive mice. Therefore, the factors in F-CM are able to support proliferation
and differentiation of the MCCP, but not the more primitive IL-3 dependent bone
marrow progenitor. The MCCP may represent a more differentiated cell than its
bone marrow counterpart. Thereby during Nb infection, the more primitive bone
marrow mast cell progenitor may be acted on in vivo to produce MCCP capable of
responding to soluble factors found in F-CM. The fact that F-CM does not produce
mast cell colonies in bone marrow cultures is further evidence that F-CM does not
contain IL-3.
Non-IL-3 MCCP support provided by F-CM cannot be replaced by other known
cytokines. Fibroblasts are known to make soluble cytokines (Li and Johnson, 1985).
Because the cloning of bone marrow cells in the presence of F-CM yielded numerous
granulocytic and macrophage colonies (Table 7), one can conclude that such
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Growth factors present in F-CM do not produce mast cells from
bone marrow progenitors

Table 7. Growth factors present in F-CM do not produce mast cells from bone marrow progenitors.
BALB/c mice were infected with 1,000 Nb L3 infective larvae and sacrificed at day 14 of the infection.
A single cell suspension was prepared from their bone marrow and the cells were cloned in
methylcellulose at a concentration of 2xl04 per ml using 10% (v/v) PWM-CM, WEHI-3 conditioned
medium as a source of IL-3, lOx L929 conditioned medium as a source of M-CSF, lOx F-CM from
monolayers of embryonic skin, 25 units per ml GM-CSF, or lOx cDMEM as a control. After eight days
in culture, colonies were enumerated and the entire plate was harvested. Cytospin slides were stained
with May-GrUnwald/Giemsa and differential cell counts were made. The percentage of mast cells was
confirmed with 0.2% toluidine blue stain. Legend for the differential cell count is as follows: Mast= mast
cells, Blast= blast cells, Ml/>= macrophages, PMN= polymorphonuclear leukocytes, Eos= eosinophils.
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conditioned medium contains known colony stimulating factors such as M-CSF and
GM-CSF.

To determine if the proliferation and differentiation of the MCCP

provided by F-CM can be replaced by these or other known cytokines, a series of
experiments were conducted where Nb-MLN were cultured in the methylcellulose
cloning system in the presence of various factors (Table 8). Although the MCCP
from Nb-MLN responded to numerous preparations of F-CM from either 3T3
fibroblasts or monolayers of embryonic skin, no mast cell colonies were formed when
Nb-MLN were cultured with known colony stimulating factors, interleukins other than
IL-3, or many other known cytokines. Potencies of all colony stimulating factors
were confirmed in bone marrow cultures, IL-2 supported proliferation of an IL-2
dependent cell line, and efficacy of IFN was confirmed by the ability to protect L929
fibroblasts from the cytopathic effect of vesicular stomatitis virus.
To address the possibility that a combination of known factors is responsible for
support of the MCCP, Nb-MLN were cultured in the presence of 100 units per ml
of IL-2, IL-4, GM-CSF, and G-CSF as well as 10% (v/v) of lOx concentrated L929
conditioned medium as a source of M-CSF. This mixture of factors produced no
mast cell colonies.
Similar response pattern is observed in liquid culture. A liquid culture system was
sought which would allow us to directly measure cell proliferation to confirm the
pattern of responses observed in the methylcellulose cloning culture system. We felt
that this could be best accomplished by using a partially purified preparation of
MCCP; therefore, Percoll gradients were used to partially purify the MCCP away
from the bulk of the lymphocytes. Preliminary experiments were conducted using
Percoll concentrations between 20 and 80%, and these studies indicated that the
MCCP was buoyant over a density of 40 to 60% Percoll. To better define the density
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Factors unable to support development of MCCP

Table 8. Factors unable to support development of MCCP. 6x1D5 Nb-MLN were cloned in
methylcellulose which was supplemented with the listed factors at doses shown. See Materials and
Methods for a description of the source and purity of each factor. On day 13 of culture, the cultures
were observed for colony formation. F-CM and PWM-CM positive controls were included in each assay.

of the MCCP, Nb-MLN were subjected to Percoll fractionation at 3% intervals
between 40 and 60% Percoll and were cultured in a liquid culture system. To
optimize the liquid culture system, a series of experiments were conducted which
tested various densities at which to plate the final cell preparations and the length
of culture which provided the best stimulation index during the time of MCCP
proliferation. Best results were obtained using 2x1D5 cells per well, an eight day
culture period, and a terminal 24 hour pulse with [3H]TdR. Because the media
control of each Percoll fraction exhibited a slightly different value for the cpm
generated, data is shown as a stimulation index for each fraction (Table 9). The
stimulation index was calculated by dividing the cpm of the factor added cultures by
the cpm of the media control.

The 54% Percoll interface provided a higher

percentage of MCCP than any other fraction (Table 9), and that percentage of
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Percoll enrichment of MCCP in Nb-MLN

Table 9. Percoll enrichment of MCCP in Nb-MLN. Nb-MLN were pelleted by centrifugation and
overlaid with various dilutions of Percoll. After centrifugation at 800 x g for 15 minutes, buoyant cells
were removed and washed twice. Cell concentrations were normalized to 2xl06 cells per ml, and 0.1 ml
samples of each were cultured in a rich cloning medium alone or in the cloning medium supplemented
with 10% (v/v) PWM-CM and 5% \v/v) 30x 3T3 F-CM. After seven days of culture, wells were given
a terminal 24 hour pulse with 1 µCi [· H]TdR. Data is shown as a stimulation index which was calculated
from the mean of six replicate wells which received factor divided by the mean of the corresponding six
replicate wells which received only medium.

Percoll was employed in all subsequent liquid culture experiments. The 54% Percoll
fraction corresponds to a density of approximately 1.062 grams per ml. This value
is between the density of IL-3 dependent bone marrow progenitors (1.030 grams per
ml) and the density of mature mast cells (1.10 grams per ml). At the time of harvest,
viable cells in PWM-CM cultures included 30% mast cells, 64% blast cells, 5%
lymphocytes, and 1% macrophages, whereas F-CM stimulated cultures were 88%
mast cells, 6% blast cells, 5% lymphocytes, and 1% macrophages.

Table 10

compares proliferation in PWM-CM stimulated wells to those supplemented with F
CM, IL-3, IL-4, GM-CSF, and murine serum fibronectin. As observed in the
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Liquid culture of MCCP enriched Nb-MLN

Table 10. Pattern of response in liquid culture is similar to methylcellulose culture. Nb-MLN were
enriched for MCCP by separation over a 54% Percoll gradient. Buoyant cells were washed and cultured
at 2xlo-5 cells per well in a 96-well plate in a rich culture medium (see Materials and Methods). Cultures
were supplemented as indicated with various dilutions of PWM-CM, purified IL-3, rIL-4, purified GM
CSF, rG-CSF, purified murine serum fibronectin, 15x F-CM from monolayers of 3T3 fibroblasts, or
cDMEM which had been concentrated ten-fold as a media control. After seven days of culture, wells
were given a terminal 24 hour pulse with 1 µCi [3H]TdR. Data is shown as cpm ± standard deviation.
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methylcellulose cultures, no level of purified IL-3 tested produced the magnitude of
response observed in cultures stimulated with PWM-CM or F-CM prepared from
monolayers of 3T3 fibroblasts.

rIL-4 alone produced some response in these

cultures; however, the viable cell phenotype at the time of harvest included 55%
lymphocytes and only 21% mast cells. Purified GM-CSF, G-CSF, or murine serum
fibronectin produced little or no stimulation in these cultures. Combinations of IL3 and IL-4 produced better stimulation than either factor separately. We interpret
these data to mean that a liquid culture system is an efficient and reliable method
to quantitate the response of different factors on Nb-MLN cells which have been
enriched for the MCCP. Further, as observed in methylcellulose cultures, F-CM is
better able to support the proliferation of the MCCP than a purified preparation of
IL-3.
NGF does not support the proliferation and differentiation of the MCCP.
Administration of NGF to neonatal rats has been shown to induce a dose dependent
increase in the numbers of both connective tissue mast cells and mucosa! mast cells
(Bienenstock et al., 1987). Because of this activity and the fact that fibroblasts are
known to produce NGF (Oger et al., 1974), we investigated the possibility that NGF
was the cytokine in F-CM which was causing the proliferation and differentiation of
the MCCP. First, we cultured Nb-MLN in the presence of NGF from two sources
(see Materials and Methods). Mast cell colonies were not observed at any dilution
of either preparation (Table 8); therefore, NGF could not be the sole factor in F
CM that supports development of the MCCP. To determine if NGF in F-CM may
be essential in the support of the MCCP by working in conjunction with other factors
found in F-CM, NGF was removed by affinity chromatography using polyclonal anti
NGF or monoclonal anti-NGF. Figure 14 compares the result of anti-NGF absorbed
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Figure 14.

NGF does not play a role in the development of the MCCP. F-CM
from monolayers of embryonic skin was concentrated SO-fold and NGF
was removed by affinity chromatography using an excess of an
ammonium sulfate precipitated polyclonal antibody or monoclonal
anti-NGF (Beta-1 clone). F-CM was similarly passed over a control
column of normal mouse lg. Effluent of each column was used at
10% (v/v) in a methylcellulose cloning of Nb-MLN as described for
Figure 12. F-CM absorbed with either polyclonal or monoclonal anti
NGF did not support neurite outgrowth. Further, NGF was eluted
from the affinity columns with glycine HCL at pH 2.8, dialyzed against
phosphate buffered saline, and added to methylcellulose cultures of Nb
MLN at 10% (v/v). Cultures were enumerated and harvested as
before.
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F-CM to the effluent of a control column which had been coated with IgG from
normal mouse serum. The number of mast cell colonies produced from Nb-MLN in
methylcellulose cultures given the F-CM which had been absorbed with anti-NGF
was not statistically different (P>0.4) from cultures in which F-CM from the control
column was used. When the material was eluted from the affinity columns and the
eluate was added to methylcellulose cultures of Nb-MLN, no mast cell colonies
developed (Figure 14). Taken together, these data demonstrate that NGF does not
play a role in the growth and differentiation of the MCCP.
Coculture with heparin or glycosaminoglycans does not promote proliferation or
differentiation of the MCCP.

To investigate the possibility that degranulation

products of mast cells may play a role in the development of the MCCP in Nb
infected mice, Nb-MLN were cultured in the presence of 50 µg per ml of heparin
or various glycosaminoglycans including keratan sulfate, hyaluronic and chondroitin
sulfates A, B, and C. No mast cell colonies developed in any of these cultures (data
not shown).
Physicochemical characteristics of the factor in FC-CSF that supports the MCCP.
To begin the purification of the factor or factors in F-CM which support the MCCP,
a series of experiments was conducted to determine the physical properties of the
molecule which displays that biological activity. Figure 15a demonstrates that the
MCCP supporting activity of F-CM is destroyed by incubation with either trypsin or
chymotrypsin. The activity is also destroyed by heating the F-CM to 70 ° C for one
hour whereas heating at 57 ° C had little effect on the factor (Figure 15b). When an
ether extraction of F-CM was conducted, all activity remained in the aqueous fraction
(data not shown). Serial ultrafiltration of F-CM was conducted using a 100 kD, 50
kD, and 5 kD Amicon membrane under high salt (1.5 M NaCl) conditions to get
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Figure 15.

Characteristics of MCCP-supporting activity in conditioned medium
from fibroblasts. Nb-MLN were cloned in methylcellulose using various
preparations of F-CM (as described) as the only source of growth
factors. After 13 days of culture, colonies were enumerated, harvested,
and differential cell counts were made. Data are shown as colonies per
plate times percentage mast cells ± standard error. All cultures
contained greater than 71% mast cells.
(A) Enzyme treatment. F-CM from monolayers of embryonic
skin was concentrated 50-fold and incubated with six units
insoluble trypsin or ten units insoluble chyll).otrypsin which was
bound to beaded agarose for one hour at 37 C. The beads were
removed by centrifugation.
(B) Heat treatment. F-CM from monolayers of �mbryorµc
skin was concentrated ten-fold and then heated at 57 C or 70 C
for one hour.
(C) Amicon ultrafiltration. 3T3 F-CM was brought to 1.5 M
NaCl and fractionated by sequentially employing YMlOO, XM50,
and YM5 membranes. Each fraction was concentrated ten-fold
and dialyzed against medium before use.
(D) Ammonium sulfate precipitation. F-CM from monolayers
of embryonic skin was concentrated 25-fold and then subjected
to sequential ammonium sulfate precipitation at 50, 60, 70, and
80% saturation. The supernatant from each precipitation was
subjected to the next higher level of saturation, whereas the
precipitate was resuspended in distilled water and desalted by
dialyzing against phosphate buffered saline.
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Figure 16.

Separation of F-CM by sequential Amicon filtration. 3T3 F-CM was
brought to 1.5 M NaCl and fractionated by sequentially employing
YMlOO, XM50, and YM5 membranes. The quality of separation was
determined by HPLC with a size exclusion column (GPC 300,
SynChrom, Inc., Lafayette, IN). Data shown are OD280 tracings of (A)
the 50-100 kD fraction and (B) the 5-50 kD fraction taken at a flow
rate of 1.5 ml per minute. At this flow rate, the bovine serum albumin
standard peaks at 5.82 minutes.
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optimal separation of proteins. No activity was found in the 50-100 kD or > 100 kD
fractions, whereas the 5-50 kD fraction supported mast cell colony formation from
Nb-MLN (Figure 15c).
F-CM was also subjected to sequential precipitations with ammonium sulfate at
50, 60, 70, and 80% saturation by removing the supernatant from each precipitation
and subjecting it to the next higher level of saturation. Figure 15d demonstrates that
only the 70% precipitated fraction retained the ability to produce mast cell colonies
from the MCCP. Sequential ammonium sulfate precipitated preparations were also
added to partially purified MCCP in liquid culture.

In agreement with the

methylcellulose data, Table 11 demonstrates that only the 70% ammonium sulfate
precipitated fraction exceeded the level of proliferation supported by the
nonprecipitated F-CM. Over 80% of the cells in these wells were mast cells. To
determine if this partially purified preparation was now able to produce mast cell
colonies from bone marrow mast cell progenitors, bone marrow cells were cultured
in the presence of each of the ammonium sulfate precipitated fractions. Colonies of
macrophages, neutrophils, and undifferentiated blasts were produced from factors
which precipitated at each level of saturation, with the 60% and 70% fractions
displaying the best growth. However, no mast cell colonies were produced from any
of the fractions, and only the PWM-CM positive control produced mast cells ( data
not shown). Taken together these data suggest that the factor in F-CM which causes
proliferation of the MCCP is protein in nature, has a size between 5 kD and 50 kD
and is precipitated with 70% saturated ammonium sulfate.
The factor in 3T3 F-CM that supports proliferation of the MCCP appears to be
between 13 and 30 kD. To further characterize the factor which causes proliferation
of the MCCP, a fractionation of 3T3 F-CM was conducted using a Sephadex G-75
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Support of MCCP proliferation by ammonium sulfate
precipitated fractions of F-CM in liquid culture

Table 11. Support of MCCP proliferation by ammonium sulfate precipitated fractions of F-CM in liquid
culture. F-CM from monolayers of embryonic skin was concentrated 25-fold and then subjected to
sequential ammonium sulfate precipitation at 50, 60, 70, and 80% saturation. The supernatant from each
precipitation was subjected to the next higher level of saturation, whereas the precipitate was
resuspended in distilled water and desalted by dialyzing against phosphate buffered saline. Nb-MLN
were enriched for MCCP by separation over a 54% Percoll gradient. Buoyant cells were washed and
cultured at 2xla5 cells per well in a 96-well plate in a rich culture medium (see Materials and Methods).
Cultures were supplemented as indicated with 20% added factor. Volumes of precipitated factor added
were normalized to the starting volume before fractionation. After seven days of culture, wells were
given a terminal 24 hour pulse with 1 µCi [3H]TdR. Data is shown as cpm ± standard deviation of six
replicate wells.
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sizing column, and the fractions were added to partially purified MCCP in the liquid
culture assay. At physiologic salt conditions, no biological activity was recovered in
any fractions; however, when the fractionation was repeated at high salt conditions
(1.5 M NaCl), a peak of proliferative activity occurred at between the 13 to 30 kD
region of the separation (Figure 17). These data suggest that the factor which causes
proliferation of the MCCP has a molecular weight between 13 and 30 kD.
MCCP can undergo proliferation without granulation. To confirm that the cells that
were proliferating in response to the 30 kD fraction were mast cells, some wells were
selected for phenotyping at day eight of culture. May-GrOnwald/Giemsa staining
demonstrated that 99% of the viable cells were blast cells and only 1% were mast
cells.

Some wells were allowed to continue in culture without additional

supplementation, while other wells were supplemented with unfractionated F-CM.
After an additional three days of culture, both groups were harvested and
phenotyped.

The wells that had not received supplementation with the

unfractionated F-CM continued to blast in response to the 30 kD fraction. These
wells contain 90% nongranulated cells which were primarily undifferentiated blasts
and only 10% mast cells (Figure 18A). In contrast, the wells that received
supplementation with unfractionated F-CM were found to contain 96% mast cells,
and no blast cells remained in these cultures (Figure l8B). These granulated cells
were confirmed to be mast cells as evidenced by their metachromatic granules when
stained with toluidine blue (Figure 18C). In addition, the blast cells tended to
proliferate in clumps, whereas once the cells became granulated, they moved apart.
This separation may be caused by repulsion of the negatively charged proteoglycan
that is found in the granulated cells. These data suggest that F-CM contains at least
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Figure 17.

G-75 fractionation of MCCP-supporting activity in liquid culture. 3T3
F-CM was concentrated 50-fold and was fractionated over Sephadex
G-75 under high salt conditions (1.5 M NaCl). 1251 chymotrypsinogen
was added to each sample before fractionation as an internal molecular
weight control. Fractions were dialyzed against medium before use.
Nb-MLN were enriched for MCCP using 54% Percoll and cultured at
2x1()5 cells per well in a 96-well plate in 100 µl of a rich cloning
medium plus 100 µl of G-75 fraction for seven days. Cultures received
1 µCi [3H]TdR for the terminal 24 hours of culture. Cultures were
harvested on glass filter strips and incorporated radioactivity was
measured by liquid scintillation counting. Data is expressed as cpm ±
standard error from quadruplicate cultures.
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Figure 18.

G-75 fractions of 3T3 F-CM between 13 and 30 kD support
proliferation but not granulation of MCCP. Liquid culture of MCCP
enriched Nb-MLN was conducted in the presence of G-75 fractions of
3T3 F-CM as stated in the previous figure. At day eight of culture,
wells with G-75 fractions 44 to 58 were supplemented with 10% (v/v)
unfractionated 3T3 F-CM, and duplicate wells were left
unsupplemented as a control. Cells in all wells were then harvested
three days later (day 11 of culture) and phenotyped using both May
GrOnwald/Giemsa and 0.2% toluidine blue stains.
(A) Contents of wells receiving no supplementation with
unfractionated 3T3 F-CM were stained with May
GrOnwald/Giemsa and cells were found to be 90%
nongranulated and only 10% mast cells. The majority of the
cells were large undifferentiated blast cells.
(B)
Contents of wells receiving supplementation with
unfractionated 3T3 F-CM were also stained with May
GrOnwald/Giemsa and found to be 96% granulated cells with
typical mast cell phenotype. No blast cells at all were found in
these cultures.
(C) The granulated cells in the wells supplemented with
unfractionated 3T3 F-CM contained metachromatic granules
when stained with 0.2% toluidine blue.
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two factors which are important for mast cell development. One factor is between
13 and 30 kD and causes proliferation of the MCCP. A second factor of unknown
molecular weight is responsible for the granulation of the MCCP. This demonstrates
that proliferation and granulation can be uncoupled in vitro. Attempts to purify these
factors to homogeneity using HPLC are underway.
Mast cells produced from MCCP in the presence of F-CM display granule
heterogeneity. To determine if mast cells produced in the presence of F-CM differed
from those produced with PWM-CM, mast cell colonies produced from each factor
were harvested and stained with alcian blue and counterstained with safranin. Figure
19 shows that while PWM-CM produced mast cells which displayed only blue
granules, F-CM produced mast cells which showed distinct granule heterogeneity with
a mixture of blue and red staining granules. Mast cells produced by culture with a
combination of PWM-CM and F-CM showed the same pattern of mixed granules
observed in F-CM alone. In addition, the F-CM produced mast cells which stained
faintly with the fluorescent stain berberine sulfate, whereas PWM-CM produced mast
cells which were berberine negative. Although neither group stained with Bl.1
antibody for the connective mast cell marker globopentaosylceramide, nearly all
(98%) mast cells produced in response to PWM-CM were positive for the mucosal
mast cell marker that binds antibody produced by B24.l; however, only 7% of mast
cells produced in response to F-CM were B24.l +. These data suggest that mast cells
produced in the presence of F-CM are taking on a connective tissue mast cell
phenotype.
Nb-infected W /W v mice fail to produce the MCCP. To determine if the mast cell
deficiency of W /W or Sl/Sld mice could be attributed to a failure by either strain
to produce the MCCP, both strains of mice and their littermates were infected with
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Figure 19. Mast cells produced from MCCP in the presence of F-CM display granule
heterogeneity. Nb-MLN were cloned in methylcellulose in the presence of 10% (v/v)
PWM-CM (A) or 10% (v /v) 15x 3T3 F-CM (B). After 13 days in culture colonies
were harvested and stained with alcian blue and counterstained with safranin (x1400).
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Nb and their Nb-MLN were cloned in methylcellulose in the presence of 3T3 F-CM
as the only source of growth factors or were cloned in the presence of PWM-CM.
These experiments demonstrated that Nb-MLN from W /W mice produced mast cell
colonies in response to PWM-CM but not in response to F-CM. This suggests that
W /W make an IL-3 dependent mast cell progenitor but not the MCCP. In contrast,
Nb-MLN from Sl/Sld mice produced mast cell colonies in response to either stimulus.
To better understand the W mutation, W /W, W/ +, W/ +, and + / + mice were
infected with Nb, and their Nb-MLN were cloned in methylcellulose in the presence
of 3T3 F-CM or PWM-CM. Figure 20 shows that in agreement with earlier results,
Nb-MLN from W /W mice failed to make mast cell colonies in response to F-CM,
whereas all genotypes of the littermates as well as Sl/Sld mice produced numerous
mast cell colonies. It is important to note that Nb-MLN from W/W mice did make
numerous mast cell colonies in response to PWM-CM. We interpret this data to
mean that W /W mice respond to the Nb infection by trafficking IL-3 dependent
mast cell progenitors into the mesenteric lymph node; however, these mice are not
able to respond by producing the MCCP as do their littermates or the Sl/Sld mouse.
Bone marrow of Nb-infected mast cell-deficient mice do not contain MCCP. As
previously shown, bone marrow from normal Nb-infected BALB/c mice contains a
normal proportion of mast cell progenitors that respond to PWM-CM, but does not
contain MCCP (Table 7). It is possible that MCCP were being produced in response
to Nb infection in the W /W mouse and were not seen in the mesenteric lymph node
only because of a failure to traffic there. To investigate this possibility, bone marrow
cells from Nb-infected W /W, W/ +, W/ +, + / +, and Sl/Sld mice were cloned in
methylcellulose in the presence of 3T3 F-CM or PWM-CM. Table 12 shows that all
mice tested produced mast cell colonies in response to PWM-CM; however, none of
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Figure 20.

Nb-infected W/W mice fail to produce the MCCP. Mast cell-deficient
mice and normal littermates were infected with 800 Nb l3 infective
larvae and sacrificed at day 14 of the infection. A single cell
suspension was prepared from the mesenteric lymph node, ang the cells
were cloned in methylcellulose at a cell concentration of 6x10 cells per
ml using either 10% PWM-CM or 10% 3T3 F-CM which had been
concentrated 30-fold. After 13 days in culture, colonies were
enumerated and the entire plate was harvested. Cytospin slides were
stained with May-GrOnwald/Giemsa and differential cell counts were
made. The percentage of mast cells was confirmed with 0.2% toluidine
blue stain. Standard error is shown.
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Bone marrow of Nb-infected mice does not contain MCCP

Table 12. Bone marrow of Nb infected mice does not contain MCCP. Mast cell-deficient mice and
normal littermates were infected with 800 Nb L3 infective larvae and sacrificed at day 14 of the infection.
A single cell suspension was prepared fro!P the bone marrow and the cells were cloned in
methylcellulose at a cell concentration of 2x10 cells per ml using either 10% PWM-CM or 10% 3T3
F-CM which had been concentrated 30-fold. After eight days in culture, colonies were enumerated and
the entire plate was harvested. Cytospin slides were stained with May-GrUnwald/Giemsa and
differential cell counts were made. The percentage mast cells was confirmed with 0.2% toluidine blue.
Data are shown as colonies per plate. Legend for the differential cell count is as follows: Mast=mast
cells, Blast=blast cells, M</J =macrophages, PMN = polymorphonuclear leukocytes, Eos=eosinophils.
Standard error is shown.
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the bone marrow cultures produced mast cell cultures in response to F-CM. A
similar pattern was observed when the bone marrow cells of naive mast cell-deficient
mice and their normal littermates were cloned in methylcellulose in the presence of
PWM-CM or F-CM from trypsinates of embryonic skin from BALB/c mice (Table
13).

These data suggest that both Sl/Sld and W /W mice and their normal

littermates have IL-3 dependent bone marrow mast cell progenitors; however, none
of the mice tested had MCCP in their bone marrow even during an infection with

Nb.

Bone marrow of naive mice does not contain MCCP

Table 13. Bone marrow of naive mice does not contain MCCP. A single cell suspension was prepared
from the bone marrow of mast cell-deficient mice.jind their + / + littermates, and the cells were cloned
in methylcellulose at a cell concentration of 2x10 cells per ml using either 10% PWM-CM or F-CM
from monolayers of embryonic skin which had been concentrated ten-fold. After eight days in culture,
colonies were enumerated and the entire plate was harvested. Cytospin slides were stained with May
Griinwald/Giemsa and differential cell counts were made. The percentage mast cells was confirmed
with 0.2% toluidine blue. Data are shown as colonies per plate. Legend for the differential cell count
is as follows: Mast= mast cells, Blast= blast cells, M</J = macrophages, PMN= polymorphonuclear
leukocytes, Eos = eosinophils.
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The spleen of Nb-infected Sl/Sl d but not W /W v mice contain a small number of
MCCP. Although the mesenteric lymph node is the draining node for the Nb
infection and is the tissue most likely to have the highest number of MCCP early
in the immune response, we wished to investigate whether the spleen of Nb-infected
mice also contained MCCP. To accomplish this, spleen cells from all four Nb
infected genotypes of the WBB6FJJ littermates (W/W, W/ +, W/ +, and + / +) as
well as Sl/Sld mice were cloned in methylcellulose in the presence of 3T3 F-CM or
PWM-CM.

Table 14 shows that 3T3 F-CM cultures demonstrated a low but

consistent production of mast cell colonies from all mice tested except the W /W
mutant. All mice tested, including W/W, produced numerous mast cell colonies in
cultures supplemented with PWM-CM. We interpret these results to mean that the
spleens of Nb-infected mast cell-deficient mice W/W and Sl/Sld contain numerous
IL-3 dependent mast cell progenitors; however, the W/W mutant differed from all
other mice tested in that it was not able to produce the MCCP.
F-CM from Sl/Sl d mice does not support the development of MCCP from normal
mice. It is clear from Figure 20 that Sl/Sld mice produce MCCP, so we investigated
the possibility that their mast cell deficiency may be caused by the failure to make
the factors found in F-CM which support the proliferation and differentiation of the
MCCP. To address this question, monolayers were prepared from skin connective
tissues of Sl/Sld mice and their +/ + littermates as well as from the mutant W/W
mice. The conditioned medium from these monolayers was concentrated ten-fold
and MCCP from the mesenteric lymph node of Nb-infected normal BALB/c mice
were cloned in methylcellulose using these conditioned medium as the only source
of growth factors.

Figure 21 demonstrates that F-CM from Sl/Sld monolayers

supported the production of only about 14% of the mast cell colonies as compared
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The spleen of Nb-infected Sl/Sld but not W/W mice contain
a small number of MCCP

Table 14. The spleen of Nb-infected SI/Sid but not W /W mice contain a small number of MCCP.
Mast cell-deficient mice and normal littermates were infected with 800 Nb L3 infective larvae and
sacrificed at day 14 of the infection. A single cell suspension wa� prepared from the spleen and the cells
were cloned in methylcellulose at a cell concentration of 6x10 cells per ml using either 10% PWM
CM or 10% 3T3 F-CM which had been concentrated 30-fold. After 13 days in culture, colonies were
enumerated and the entire plate was harvested.
Cytospin slides were stained with May
GrU nwald/Giemsa and differential cell counts were made. The percentage mast cells was confirmed
with 0.2% toluidine blue stain. Legend for the differential cell count is as follows: Mast= mast cells,
Blast= blast cells, M</> = macrophages, PMN = polymorphonuclear leukocytes, Eos= eosinophils. Standard
error is shown.
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Figure 21.

Failure of Sl/Sld F-CM to support development of MCCP. Skin
connective tissues of mast cell-deficient or + / + mice were obtained
using an air pouch technique, and monolayers were prepared from
trypsinates of those tissues. Conditioned medium from each monolayer
was concentrated ten-fold. Nb-MLN from normal BALB/c mice were
cloned in methylcellulose using various dilutions of conditioned medium
from each monolayer as the only source of growth factors. After 13
days of culture, colonies were enumerated, harvested, and a differential
cell count was done. Data is shown as colonies produced times
percentage mast cells ± standard error. All cultures except those
produced with conditioned medium from Sl/Sld mice had 68-90% mast
cells.
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to F-CM similarly produced from monolayers prepared from the + / + littermate.
However, F-CM from monolayers prepared from the mutant mouse W/W supported
the production of the same number of mast cell colonies as the + / + mouse. F-CM
produced from a monolayer prepared from kidney capsule fibroblasts of Sl/Sld mice
was also unable to support normal mast cell colony formation, producing only about
3% of the mast cell colonies produced by F-CM from monolayers of + / + mice.
These data suggest that in contrast to W/W mice, Sl/Sld fibroblasts do not make
the factor which is able to support the normal proliferation of MCCP from Nb
infected mice.

Discussion

We have been interested in developing an in vitro differentiation system whereby
any of several mast cell features can be studied by employing a late-stage mast cell
progenitor which is poised on the edge of granulation and can be stimulated with
defined factors to produce specific phenotypic changes. To accomplish this, we have
investigated the biology of mast cell differentiation and have made several original
findings listed as follows:
1) We have identified a late, committed stage in the differentiation of the
mast cell progenitor (the MCCP) whose proliferation and differentiation can
be supported in the absence of IL-3 when it is cultured on a fibroblast
monolayer derived from embryonic skin or the 3T3 cell line.
2) The IL-3 independent support of this progenitor does not require cell-cell
contact with the fibroblast monolayer, but proliferation and granulation are
regulated by a balance of at least two separate soluble factors which are
released from fibroblasts.
3) The mast cell deficiency of two strains of mutant mice can be directly
attributed to the inability of these mice to produce either the MCCP or the
factors which support this progenitor.
Our first major finding was the identification of a unique, committed progenitor
for mast cells. We believe that the MCCP is a unique cell because it is harvested
120

121
from a unique environment. We have shown that the mesenteric lymph node of Nb
infected mice is very active, having a size about five to ten-fold larger than that of
naive mice and supporting a stimulation index of 12.45 during lymphocyte
proliferation assays. In addition, IL-3 levels undergo a dramatic increase; thereby
peaking several days before the highest percentage of MCCP can be harvested from
the node. Others have previously shown that during Nb infection, IgE levels rise
sharply (Ishizaka et al., 1976) and virtually all B lymphocytes in the mesenteric lymph
node express low affinity IgE receptors as demonstrated by the CD23 marker on
their surface (Katona et al., 1983). Any of these physiological changes, either alone
or in combination, may be responsible for regulating the progression of the stage of
differentiation from the more primitive IL-3 dependent bone marrow mast cell
progenitor to the MCCP. The most likely possibility is that the remarkably elevated
IL-3 levels in the node are instrumental in bringing about the progression of the IL3 dependent progenitor to the more differentiated stage of MCCP. This theory is
supported by the observation of Fujita et al. (Fujita et al., 1988) that mast cells which
had been cultured from bone marrow in the presence of PWM-CM had the ability
to increase in number in the absence of IL-3 when they were transferred onto
monolayers of NIH/3T3 fibroblasts. Our interpretation of the data presented here
is that the MCCP is a later stage of development of the bone marrow-derived mast
cell progenitor and not an entirely separate lineage. This conclusion is based upon
the fact that whether Nb-MLN are cloned in the presence of PWM-CM or F-CM,
approximately the same number of mast cell colonies are produced and cloning the
Nb-MLN in the presence of a combination of PWM-CM and F-CM does not
appreciably increase the numbers of mast cell colonies produced above the number
of colonies produced from PWM-CM or F-CM alone. If two separate lineages of
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mast cell progenitors were present in equal numbers in the mesenteric lymph node
in response to the Nb infection, one would expect the combination of F-CM and
PWM-CM to produce twice the number of mast cell colonies as either source of
growth factors used separately. Nonetheless, the possibility that the MCCP is an
entirely separate mast cell lineage which does not require IL-3 at any stage of
development cannot be entirely ruled out. Whether a separate lineage or not, it is
clear that MCCP are present in high levels in the mesenteric lymph node of Nb
infected mice; however, no mast cell progenitors (IL-3 dependent or IL-3
independent) are present in the mesenteric lymph node of naive mice.
We have used the term "mast cell-committed progenitor". By use of the term
"committed" we mean to imply not only that the stage of differentiation is later than
a more primitive bone marrow-derived progenitor, but that the progenitor is
incapable of becoming anything other than a mast cell. This was demonstrated by
the fact that when the MCCP was cultured in the presence of a mix of colony
stimulating factors and growth factors such as PWM-CM, 99% of the colonies formed
were mast cell colonies, and only an occasional macrophage colony was observed.
These data also demonstrate that the mast cell progenitor can be isolated in an
environment which is virtually uncontaminated with other hematopoietic progenitors.
The affinity that the MCCP has for the embryonic skin monolayer is of both
practical and theoretical interest.

In a practical application, we used this

phenomenon of intercalation as an effective yet simple method to separate T cells
from the MCCP. The basis for this affinity is currently unknown. Monolayers of
3T3 fibroblasts were poor at binding and holding the MCCP; however, the MCCP
that did adhere to the monolayer proliferated much faster thereby producing more
total mast cells than the embryonic skin supported cultures by the end of the culture
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period. We believe the decreased intercalation of the MCCP into 3T3 monolayers
may be simply mechanical in nature rather than a quantitative difference in the
number of adherent sites of the surface of the cells composing the monolayers.
When observed by phase contrast microscopy, embryonic skin monolayers are seen
as a three-dimensional connective tissue microenvironment whereas 3T3 monolayers
are much more flattened into a more two-dimensional appearance. The three
dimensional characteristic of the embryonic skin monolayer may provide more
available surface area for the MCCP and allow for a more complete intercalation
into the monolayer. The methylcellulose data (Figure 6) indicate that 3T3 F-CM is
better able to support proliferation than F-CM from embryonic skin monolayers. So
it appears that the MCCP that do remain associated with the 3T3 monolayer
proliferate faster to produce more total mast cells because the monolayer is
producing more of the factor which supports proliferation than is the case with
monolayers of embryonic skin.
The intercalation phenomenon is also of theoretical interest. Considering that
the circulation is known to contain a small number of IL-3 dependent mast cell
progenitors but no mast cells (Sonoda et al., 1983), it can be concluded that mast
cell progenitors in vivo do not differentiate until they migrate into a connective tissue
microenvironment. It is reasonable to assume that intercalation into connective
tissue serves to increase the concentration gradient of fibroblast-derived granulation
factors to which the mast cell progenitor is exposed. Thus, mast cell progenitors
granulate only after leaving the blood stream, and the granulation signal is not actual
cell contact with the fibroblast, but instead is the exposure to high concentrations of
fibroblast-derived granulation factors brought about by the intercalation.
In addition to IL-3 independence, the MCCP differs from the bone marrow mast
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cell progenitor in cell density. Young et al. (Yung et al., 1983) have shown that bone
marrow mast cell progenitors have a cell density of about 1.030 grams per ml
whereas immature mast cells are about 1.10 grams per ml. Our data demonstrate
that the peak recovery of MCCP occurred when 54% Percoll was used indicating that
the density of the MCCP falls between these two values at 1.062 grams per ml.
Some MCCP were also recovered with lower percent Percoll indicating that they are
less dense. These data may reflect an ongoing progression in differentiation from the
bone marrow progenitor to the mature mast cell.
The second major finding of these studies is that the IL-3 independent
proliferation and differentiation of the MCCP does not require cell-cell contact with
the fibroblast monolayer.

The mast cell colony formation from MCCP in

methylcellulose is mediated by soluble factors which are released from monolayers
of embryonic skin or 3T3 fibroblasts. The factor which supports the colony formation
is not IL-3. The evidence for this includes the fact that this factor is produced
constitutively by 3T3 fibroblasts, and similar fibroblast cell lines have been shown not
to make IL-3 (Fujita et al., 1988; Li and Johnson, 1985) or IL-4 (Fujita et al., 1988).
Also, anti-IL-3 hyperimmune serum was not able to absorb the mast cell colony
stimulating activity from F-CM. Finally, F-CM from monolayers of either embryonic
skin or 3T3 fibroblasts was unable to support mast cell colony formation from IL-3
dependent bone marrow mast cell progenitors. This failure to support these more
primitive mast cell progenitors is important not only in demonstrating that this factor
is not IL-3, but also is valuable in identifying an important difference between the
IL-3 dependent bone marrow mast cell progenitor and the MCCP. Of these two
cells, only the MCCP can form colonies in the presence or absence of IL-3.
Having confirmed that the fibroblast-derived factor which supports colony
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formation of the MCCP was not IL-3, we attempted to replace that activity with
known growth factors and other cytokines. An extensive number of cytokines were
assayed for their ability to produce colony formation from the MCCP including
commercial sources of IL-1, IL-2, IL-4, G-CSF, GM-CSF, M-CSF, NGF, epidermal
growth factor, interferons (alpha, beta, and gamma), tumor necrosis factor,
fibronectin, and a mixture of interleukins and colony stimulating factors. When all
factors tested produced no mast cell colonies we concluded that F-CM contained a
novel colony stimulating factor.
We initiated a series of studies to characterize the MCCP proliferation factor
and found it to be a protein with molecular weight of 5-50 kD which could be
precipitated with 70% ammonium sulfate. The most exciting finding was noted
when F-CM was fractionated over a Sephadex G-75 sizing column, and it was
observed that the fractions representing molecules of 13 to 30 kD was able to
support proliferation but not granulation of a partially purified preparation of MCCP.
In addition, the blasting MCCP became granulated mast cells when unfractionated
F-CM was added to the culture. These data indicate F-CM contains at least two
factors which are important for mast cell development: one factor which is between
13 and 30 kD causes proliferation of the MCCP while a second factor causes the
MCCP to differentiate into a mature mast cell.
We have shown the MCCP to be a bipotent mast cell progenitor in that it is
capable of developing into a mucosal mast cell in the presence of IL-3 or PWM
CM, but begins to take on a connective tissue phenotype when cultured on a
monolayer of 3T3 fibroblasts or in the presence of F-CM. Mast cells produced in
these cultures were shown to stain with berberine sulfate indicating the presence of
heparin whereas MCCP cultured only with IL-3 did not. Also, mast cells produced
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in the presence of F-CM display a mixed pattern of red and blue granules when
stained with alcian blue and counterstained with safranin. Thus the mast cells
produced in the presence of F-CM appear to be taking on a connective tissue mast
cell phenotype, and this remains true even when cultures are supplemented with both
F-CM and PWM-CM. This demonstrates that the granulation factor present in F
CM is capable of producing the connective tissue mast cell phenotype without the
need of cell-cell contact with the fibroblast microenvironment.
The discovery that proliferation and granulation can be uncoupled in vitro, taken
together with the finding that the MCCP is a bipotent mast cell progenitor, provides
opportunities for new and exciting studies and has made possible the development
of a focused in vitro differentiation system. Using the 13 to 30 kD proliferation
factor, we can now expand the small population of MCCP found in Nb-MLN and
clone this progenitor by limiting dilution to obtain a 100% pure population. This
pure population of MCCP is the cell population which will provide us with a unique
model for in vitro studies of gene expression. The cell may be stimulated with the
fibroblast derived granulation factor, and cellular events leading to the expression of
the connective tissue mast cell phenotype can be observed in vitro. Alternatively, the
MCCP may be stimulated with IL-3 to produce granulation and the expression of the
mucosal mast cell phenotype.
Our third major finding demonstrated that the mast cell deficiency of W/W
and Sl/Sld mice could be explained by the inability of these animals to produce
either the MCCP (W/W) or the fibroblast-derived MCCP proliferation factor
(Sl/Sld ). The mast cell deficiency in W/W mice is thought to be the consequence
of a defect at the level of the bone marrow (Kitamura and Hatanaka, 1978; Sonoda
et al., 1984 ), whereas Sl/Sld mice are thought to have a defect in the connective
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tissue microenvironment which prohibits the normal development of mast cell
progenitors (Kitamura and Go, 1979; Hayashi et al., 1985). We have shown that
mast cell-deficient W /W mice fail to make the cell (i.e. MCCP) that can respond to
the factors found in F-CM prepared from monolayers of 3T3 fibroblasts. In contrast,
Nb-MLN from Sl/Sld mice or the normal littermates of the W /W mouse (genotypes
W/ +, W/ +, or +/ +) did respond to F-CM, thereby producing numerous mast cell
colonies in the methylcellulose culture system. As shown by others (Suda et al.,
1985a), cultured mast cells from W /W mice could be cloned from progenitors
located in the bone marrow and spleen in response to PWM-CM. We believe that
the absence of the MCCP in the Nb-MLN is not due simply to a failure of the mouse
to accomplish trafficking of the MCCP to the mesenteric lymph node. The evidence
for this includes the fact that the mice did traffic PWM-CM responsive mast cell
progenitors into the mesenteric lymph node in response to the infection. Also,
MCCP could not be identified in either the bone marrow or spleen of these infected
mice. We therefore conclude that the absence of the MCCP in Nb-infected W /W
mice Nb-MLN is due to a failure of these mice to produce such a cell. This
hypothesis is supported by the recent observation by Fujita et al. (Fujita et al., 1988)
that monolayers of NIH/3T3 fibroblasts were able to support the growth of cultured
mast cells from bone marrow of +/ + mice but not W/W mice. The major
difference between that observation and our report is that they were working with
a mature, granulated cultured mast cell, whereas we are working with an in vivo
derived nongranulated mast cell-committed progenitor. Another major difference is
that while the cultured mast cell appears to require close contact with the 3T3
fibroblast, the MCCP we have described can be cloned using only the soluble factors
found in F-CM. The reason for this is unclear, but it is possible that the cultured
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mast cell may reqmre a higher concentration of the factors or may need the
additional stimulus of cell contact. Therefore, the cultured mast cell may be using
the same fibroblast derived factors for proliferation, yet still require close contact
with fibroblasts, whereas the MCCP does not.
F-CM from connective tissue monolayers prepared from Sl/Sld mice was not
able to support the normal proliferation of MCCP harvested from BALB/c mice.
This is in direct contrast to F-CM similarly prepared from monolayers of + / +
littermates or W/W mice which did support the MCCP. This result was not simply
due to a lack of all growth factor production by the Sl/Sld monolayers as F-CM from
these monolayers supported proliferation of a GM-CSF responsive cell line to a
equal degree as compared to F-CM from + / + littermates or W/W mice (data not
shown). The F-CM from Sl/Sld monolayers did support the production of a few mast
cell colonies from normal MCCP. The reduced production may be due to decreased
production of required factors or may reflect the production of a defective factor.
The data does not distinguish between these two possibilities; however, the fact that
the F-CM from Sl/Sld mice did not display the same degree of dose dependent drop
in biological activity observed in F-CM from other sources suggests that the Sl/Sld
mice may be making normal levels of a defective MCCP proliferation factor which
has a limited ability to support proliferation of the MCCP.
These data suggest that SI/Sid mice may lack connective tissue mast cells because
their fibroblasts lack the ability to produce the appropriate factor which supports the
proliferation of the MCCP. However, interesting questions that remain unresolved
are: (l)Considering the Sl/Sld mouse makes normal MCCP but not the fibroblast
derived proliferation factor to support the MCCP, why do they also lack mucosa!
mast cells? (2) Considering that W/W mice make an IL-3-dependent bone marrow
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mast cell progenitor and a normal MCCP proliferation factor, why do they also lack
connective tissue mast cells? One must consider the possibility that the MCCP
proliferation factor in F-CM is important in the production of both connective tissue
mast cells and mucosa! mast cells. Under this model, W/W mice fail to make an
MCCP because they fail to express the receptor for the proliferation factor or express
a defective receptor. This would suggest that the gene product of the W allele may
be directly or indirectly related to the receptor for the MCCP proliferation factor.
On the other hand, Sl/Sld mice make the MCCP, but either fail to make the MCCP
proliferation factor or they make a defective factor. This would suggest that the gene
product of the SI locus may be directly or indirectly related to the MCCP
proliferation factor itself. Considering the pleiotropic effects of anemia, sterility, and
lack of hair pigmentation that the mutation causes in these mice, it is possible that
the proliferation factor and its receptor may be instrumental in the normal
functioning of multiple systems.
In summary, we propose the following model (Figure 22). The primitive bone
marrow-derived mast cell progenitor requires IL-3 to proliferate and differentiate.
In past studies by many investigators, stimulation of mast cell progenitors using IL3 produced the in vitro phenomenon of the cultured mast cell. Although this culture
derived cell displays a phenotype similar to the mucosa! mast cell, the relevance to
the normal biology and differentiation of mast cells in vivo is unclear. This type of
cell can also be produced from the MCCP by culturing it in the presence of IL-3.
The MCCP is a more differentiated cell than its bone marrow counterpart, and the
appearance of the MCCP during Nb infection is a consequence of increased levels
of IL-3 and possibly other factors which cause the more primitive bone marrow IL3-dependent mast cell progenitor to progress in its development and express
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Figure 22. Proliferation and differentiation of mast cell progenitors. This figure is
a model of our hypothesis of the proliferation and differentiation of mast cell
progenitors.

PROLIFERATION AND DIFFERENTIATION OF MAST CELL PROGENITORS

Cultured
Meat Cell
Granulated,
Alcian Blue•,
Safranin-,
Berberine Sulfate-

"0�e\'>
yi.,Q,'r<'

�, v �

. ,,,..
,,,.,
�
,1\\l9,

o

MUCOAI
Mast Cell
Granulated,
Alcian Blue•,
Safranin-,
Berberine Sulfate-

IL-3-depeltdent
BoneMarrow
Meat Cell Progenitor
Undifferentiated
Blast Cell

Immune
Response
(Increased
levels of IL-3)

�

Meat Cell
Undergoing
Tnmsdlfferentlatlon

Meat Cell
Committed Progenitor
Nongranulated
Blast Cell

Alcian Blue•,
Safranin•,
Berberine Sulfate
(faint)

3olrD
1J o1,,.
IJ/11s fib r erlt
fio
9r1t11 ro611ts1 11. t,
lictor
"'1tt;o11 t, Oier,.,
ltctor er:t

Environment
change
Granulated,
Alcian Blue+,
Safranin•,
Berberine Sulfate
(faint)

--

Connective Tlaue
Meat Cell
Granulated,
Alcian Blue-,
Safranin•,
Berberine Sulfate +

....

...

(,,)

132
receptors for the fibroblast derived MCCP proliferation factor. The MCCP is a
bipotent mast cell progenitor and thus gives rise to both connective tissue mast cells
and mucosa! mast cells by proliferating in response to the same proliferation factor

in vivo. The final phenotype produced is determined separately by the influence of
the microenvironment (either connective tissue or mucosa!) in which the cell
underwent final differentiation.

The connective tissue mast cell phenotype is

produced when the fibroblast-derived granulation factor is present.

We have

described a mixed alcian blue/safranin granulated cell that stains with berberine
sulfate. In accordance with the model presented we believe this cell to be an
immature connective tissue mast cell which is becoming a mature connective tissue
mast cell. in vivo studies have shown that it may take as long as 40 days to complete
the transdifferentiation from a mucosal mast cell to a connective tissue mast cell
(Kitamura et al., 1986a). The mixed granule cell we have described may be similar
or identical to a normal transdifferentiating cell found in vivo. Thus, even after the
MCCP completes its differentiation into a mucosa! or connective tissue mast cell,
transdifferentiation between phenotypes is possible.
The committed mast cell progenitor we have described provides a narrowly
focused window on a substantial change in phenotype. It can be isolated in an
environment which is uncontaminated with other hematopoietic progenitors. The
factors it requires to proliferate and complete its differentiation are few. The MCCP,
being bipotent, is well suited for studies of mast cell heterogeneity. This cell and the
factors which drive it should provide a uniquely qualified model system for further
studies examining signal transduction and gene expression which account for the mast
cell phenotype.
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Appendix
Mast cell stains
1. Alcian blue-safranin
A. Alcian blue
0.5% alcian blue
0.3% glacial acetic acid
Mix into distilled water
B. Safranin
0.1% safranin
0.1 % glacial acetic acid
Mix into distilled water
C. Procedure: Stain with alcian blue for five minutes, rinse, stain
with safranin for five minutes, rinse.
2. May-Grunwald/Giemsa
A. May-Grunwald stock
1.2 grams May-Grunwald stain is mixed into one liter of
methanol and allowed to stand one week.
B. McJunkin-Hayden buffer
6.63 grams KH2P04
2.56 grams Na2HPQ4
Add to distilled water to make one liter.
C. Giernsa stock
Dissolve 0.5 grams of Giernsa powder in 33 ml of glycerin at 5560 ° C. Allow mixture to stay heated at 55-60 ° C for 1.5-2 hours,
then add 33 ml of methanol.
D. Procedure: Stay with May-Grunwald for four minutes and then add
McJunkin-Hayden buffer on top of stain for another four
minutes, rinse. Dilute Giemsa stock 1:10 in distilled water and
stain slide for two minutes. Rinse and air dry.
3. Toluidine blue
A. 0.1 M citric acid
0.2% toluidine blue
Mix into 50% ethanol in water
B. Procedure: Stain air dried samples for 5 minutes to one hour,
then rinse and air dry.
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Methylcellulose reagents
1. Deionized bovine serum albumin
Dissolve 20 grams bovine serum albumin in 88.4 ml deionized distilled
water overnight. Add 2 grams mixed resin beads (Bio Rad AG 501 X
8 D) for one hour. Pass through sterile gauze to remove beads. Filter
sterilize.
2. Stock 3% methylcellulose
Boil deionized distilled water and pour 300 ml into a sterile flask.
Sterilize 200 ml distilled water and store in the refrigerator. Slowly
add 30 grams methylcellulose (4,000 centipoise) to the boiled water.
Stir approximately 30 minutes until all granules look wet, then add
200 ml cold distilled water and stir for 1.5 hours. Add 500 ml of 2x
alpha MEM and stir in cold room overnight until it clears. Aliquot
into 100 ml bottles and freeze. This stock is 3% methylcellulose and
lx alpha MEM.
3. Procedure: To a sterile culture tube add 2 ml 3% methylcellulose stock,
2 ml medium mix, and cells to be cloned. Mix with a syringe and 16
gauge needle. Transfer 1.5 ml into each of two 35 mm non-tissue
culture dishes. To avoid dehydration, place two dishes of culture mix
and one dish of distilled water into a 100 mm petri dish, and culture
in a humidified incubator at 37 ° C at 5% CO2• Count and harvest
colonies of bone marrow cells at eight days. Count and harvest
colonies of spleen cells or lymph node cells at 13 days.
Enzyme-linked immunoabsorbent assay reagents
1. 5x Tris-buffered saline
12.1 grams Tris base
146.2 grams NaCl
pH to 7.5 with HCl
qs to 1,000 ml with distilled water
2. lx Tris-buffered saline
Dilute 5x Tris-buffered saline 1:5 with distilled water. Add 0.01%
sodium azide.
3. Tween, Tris-buffered saline
Add 0.5 ml Tween 20 per liter of lx Tris-buffered saline.
4. Blocking buffer
lx Tris-buffered saline
3% bovine serum albumin
5. Substrate buffer for alkaline phosphatase
1 M Tris base
0.2 ml per liter of 1.5 M MgCl2
pH to 9.8
Store at 25 ° C
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